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Abstract
The amino acid acridon-2-ylalanine (Acd) can be a valuable probe of protein dynamics either alone or as part
of a Förster resonance energy transfer (FRET) or photo-induced electron transfer (eT) probe pair. We have
previously reported the genetic incorporation of Acd by an aminoacyl tRNA synthetase (RS). However, this
RS, developed from a library of permissive RSs, also incorporates N-phenyl-amino-phenylalanine (Npf), a
trace byproduct of one Acd synthetic route. We have performed negative selections in the presence of Npf and
analyzed the selectivity of the resulting AcdRSs by in vivo protein expression and detailed kinetic analyses of
the purified RSs. We find that selection conferred a ~50-fold increase in selectivity for Acd over Npf,
eliminating incorporation of Npf contaminants, and allowing one to use a high yielding Acd synthetic route
for improved overall expression of Acd-containing proteins. More generally, our report also provides a
cautionary tale on the use of permissive RSs, as well as a strategy for improving selectivity for the target amino
acid.
In spite of its utility for studying proteins by fluorescence spectroscopy, Acd can potentially be improved by
making it longer wavelength or brighter. We reported the synthesis of Acd core derivatives and their
photophysical characterization. We also performed ab initio calculations of the absorption and emission
spectra of Acd derivatives, which agree well with experimental measurements. The amino acid
aminoacridonylalanine (Aad) was synthesized in forms appropriate for genetic incorporation and peptide
synthesis. We show that Aad is a superior FRET acceptor to Acd in a peptide cleavage assay, and that Aad can
be activated by an aminoacyl tRNA synthetase for genetic incorporation. Together, these results show that we
can use computation to design enhanced Acd derivatives which can be used in peptides and proteins.
Finally, the Aad synthesis has been improved and it will be further tested in vivo incorporations into proteins,
and alkylated Aad core analogs show improved brightness making their use as amino acids promising.
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 ABSTRACT 
THE DEVELOPMENT OF INTRINSICALLY FLUORESCENT UNNATURAL AMINO ACIDS 
FOR IN VIVO INCORPORATION INTO PROTEINS 
 
Itthipol Sungwienwong 
Professor E. James Petersson 
 
The amino acid acridon-2-ylalanine (Acd) can be a valuable probe of protein 
dynamics either alone or as part of a Förster resonance energy transfer (FRET) or photo-
induced electron transfer (eT) probe pair.  We have previously reported the genetic 
incorporation of Acd by an aminoacyl tRNA synthetase (RS). However, this RS, developed 
from a library of permissive RSs, also incorporates N-phenyl-amino-phenylalanine (Npf), 
a trace byproduct of one Acd synthetic route.  We have performed negative selections in 
the presence of Npf and analyzed the selectivity of the resulting AcdRSs by in vivo protein 
expression and detailed kinetic analyses of the purified RSs.  We find that selection 
conferred a ~50-fold increase in selectivity for Acd over Npf, eliminating incorporation of 
Npf contaminants, and allowing one to use a high yielding Acd synthetic route for 
improved overall expression of Acd-containing proteins.  More generally, our report also 
provides a cautionary tale on the use of permissive RSs, as well as a strategy for improving 
selectivity for the target amino acid. 
In spite of its utility for studying proteins by fluorescence spectroscopy, Acd can 
potentially be improved by making it longer wavelength or brighter.  We reported the 
synthesis of Acd core derivatives and their photophysical characterization.  We also 
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performed ab initio calculations of the absorption and emission spectra of Acd derivatives, 
which agree well with experimental measurements.  The amino acid 
aminoacridonylalanine (Aad) was synthesized in forms appropriate for genetic 
incorporation and peptide synthesis.  We show that Aad is a superior FRET acceptor to 
Acd in a peptide cleavage assay, and that Aad can be activated by an aminoacyl tRNA 
synthetase for genetic incorporation.  Together, these results show that we can use 
computation to design enhanced Acd derivatives which can be used in peptides and 
proteins. 
Finally, the Aad synthesis has been improved and it will be further tested in vivo 
incorporations into proteins, and alkylated Aad core analogs show improved brightness 
making their use as amino acids promising. 
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Background  
 Anfinsen’s hypothesis is a classical postulate in molecular biology stating that the 
three-dimensional structure of a native protein in its standard physiological environment 
(solvent, pH, ionic strength, presence of other components such as metal ions or prosthetic 
groups, temperature, and other factors) is determined only by the totality of inter-atomic 
interactions within the protein and hence by the amino acid sequence.1 While it has been 
clearly shown that many proteins violate this hypothesis – for example, by requiring 
chaperones for folding2-4 – nonetheless, studies of protein structure should imitate the 
native state in a physiologically-relevant local environment as much as possible. Several 
methods have been advanced to study protein architecture such as X-ray crystallography5, 
nuclear magnetic resonance (NMR) spectroscopy6, and cryo-electron microscopy (cryo-
EM)7. Structures revealed through these methods can solve biological questions and 
provide insight into protein interactions, folding pathways, and enzymatic activities. 
However, many dynamic mechanisms remain obscure due to the limitations of these 
methods. The X-ray crystallography technique intrinsically requires the protein to be 
packed into a fine crystal lattice which freezes out most dynamics. Cryo-EM provides 
greater opportunity for flexibility, but still requires freezing the protein and deposition on 
an imaging grid. NMR spectroscopy permits solution phase characterization and the 
opportunity to observe dynamics, but NMR is limited to small proteins and cannot be used 
for real-time observations of protein motions. Thus, there is a need to complement these 
high resolution, relatively static structural methods with techniques that can provide 
information on protein motions in physiologically-relevant situations. 
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 Fluorescence spectroscopy is one valuable technique that can be used to analyze 
changes in protein structure and protein/protein interactions8-9. Fluorescent experiments 
can be performed with either intrinsically fluorescent proteins or fluorescently labelled 
proteins. Protein conformational changes can be monitored by observation of changes in 
the fluorescence of a single probe or through interactions of multiple (usually pairs) of 
probes. A change in fluorescence of a single probe can result from a change in the local 
environment of the fluorophore due to a conformational change or binding event. 
Fluorescence polarization (FP) varies with the reorientation time of the chromophore and 
can report on changes in the flexibility of a protein region or, more commonly, on a change 
in tumbling rate due to interaction with another macromolecule. Experiments using pairs 
of probes can be used to track protein structural change on the nanosecond timescale using 
distance-dependent chromophore interactions either through Förster resonance energy 
transfer (FRET) or quenching by photo-induced electron transfer (PeT). When using a 
fluorescent probe, one needs to be concerned with its ability to disrupt protein structure 
and function. These disruptions can result from the size and/or location of the fluorophores. 
The size of commonly used fluorescent labels ranges from 29820 Å3 for the green 
fluorescent protein (GFP) to 9 Å3 for thioamide substitution8. (Figure 1.1)  There are a 
variety of methods for introducing probes into proteins, which vary in complexity from 
simple cloning of the cDNA for GFP into a protein expression plasmid to the chemical 
synthesis of a protein in order to install a synthetic fluorophore.  Among these methods, 
genetic code expansion offers a near ideal combination of small probe size, potential 
flexibility in probe properties, and ease of probe introduction. 
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Figure 1.1 Chromophore size. Space-filling renderings of several chromophores, based on either 
crystal structures or ab initio calculations. The green fluorescent protein (GFP) was rendered from 
PDB ID 1GFL9. The benzylated SNAP tag protein was rendered from PDB ID 3L00. The geometry 
of tetracysteine-bound FlAsH was optimized at the HF/6-31G level, all others were optimized at 
the AM1 level (Figure adapted from Speight L.C., Moumita S., Petersson, E. J. (2014) Minimalist 
Approaches to Protein Labelling: Getting the Most Fluorescent Bang for Your Steric Buck. 
Australian Journal of Chemistry, 67, 686-700.) 
 
 
 
 
 
 
 
 
  
 
5 
Expanded Genetic Code 
 
Figure 1.2 Site-specific incorporation of unnatural amino acids. 
 
Protein translation uses transfer RNAs (tRNAs), which are aminoacylated with 
their canonical amino acids by aminoacyl-tRNA synthetase enzymes (RSs), to read triplet 
codons in messenger RNAs (mRNAs) when paired with the anticodon of the tRNA. The 
ribosome facilitates both the decoding of triplet codons on mRNAs by tRNAs, and the 
polymerization of the corresponding amino acids in order for the mRNA to be translated 
into a polypeptide chain. All proteins are ribosomally synthesized with the limitation of 20 
canonical amino acids building blocks. While a wide variety of post-translational 
modifications occur on proteins, these are generally restricted in sequence context so that 
using them to modify a protein requires the introduction of a tagging sequence which may 
alter the protein fold. Over the past three decades, approaches have been developed to 
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expand the genetic code, enabling the site-specific incorporation of unnatural amino acids 
(Uaas, also known as non-canonical amino acids or ncAAs) into proteins synthesized in 
both prokaryotic and eukaryotic cells (Figure 1.2). 
 The site-specific incorporation of a Uaa into proteins has provided new insights to 
study biological processes which are difficult and challenging to address by classical 
approaches. Peter Schultz10 developed a genetic code expansion approach that uses an 
orthogonal RS/tRNA pair to direct the incorporation of a Uaa into proteins in response to 
an unassigned codon (commonly the so-called amber stop codon, UAG) introduced at the 
desired site in a gene of interest, which is called amber suppression. Researchers can now 
incorporate Uaas into proteins in bacteria (typically Escherichia coli or E. coli), 
Saccharomyces cerevisiae, mammalian cells (a few experiments in mice have even been 
reported), Caenorhabditis elegans, Drosphila melanogaster.11 To be “orthogonal”, the 
RS/tRNA pair must meet many requirements. The specificity of the RS active site needs to 
be optimized so that it can transfer the desired Uaa, but not any of the canonical amino 
acids to the orthogonal tRNA. The orthogonal tRNA must be recognized only by the URS, 
and none of the endogenous RSs for the natural amino acids.  Finally, the URS must not 
recognize any of the endogenous tRNAs. To meet these complex requirements, Schultz 
developed a strategy of importing an RS/tRNA from another organism where the tRNA 
structure was known to be substantially different from that of the host organism.12  Initially, 
most amber suppression experimenst used orthogonal RS/tRNA pairs based on TyrRS and 
LeuRS evolved from Methanocaldococcus jannaschii (e.g. MjTyrRS, MjLeuRS) or E. coli 
(e.g. EcLeuRS). These pairs require active site evolution to facilitate binding with the 
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desired Uaa of interest. Recently the pyrrolysyl (Pyl) RS/tRNA pairs (from 
Methanosarcina barkeri and Methanosarcina mazei) have grown in popularity as Pyl is 
found in archaea, but not in bacterial or mammalian cells.13-16 Thus, PylRS/tRNA pairs are 
orthogonal in both cell types and only require evolution of the active site for the desired 
Uaa. The methods for directed evolution of the active site have been well-developed and 
are usually performed in E. coli or yeast cells. 
 
 
 
 
 
 
 
 
 
 
Figure 1.3 Positive and negative selection strategies for the generation of an orthogonal 
synthetase/tRNA pair with altered amino acid specificity for an unnatural amino acid (blue star). 
  
 Typically, several rounds of positive and negative selection are used to select an 
active site variant that allows the incorporation of the Uaa but none of the 20 canonical 
amino acids (Figure 1.3)17. The positive selection step relies on the ability of the RS/tRNA 
pair to facilitate read-through of an amber codon in an essential gene (such as antibiotic 
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resistance gene). This positive selection provides RSs in surviving colonies that can 
incorporate the Uaa and/or a natural amino acid. These RSs are then subjected to a negative 
selection procedure performed in the absence of the Uaa with the amber codon now 
encoded in toxic a gene (such as a toxic ribonuclease or barnase). The RSs that use the 
canonical amino acid will read through the amber codon and lead to cell death. After 
several rounds of positive and negative selection, only mutant RSs that can selectively 
incorporate the Uaa will survive.  This method has been used to generate RSs for more than 
100 Uaas, which have been widely employed in the production of both recombinant 
proteins for in vitro experiments and in live cell experiments.18 However, some limitations 
on protein yield exist. 
 The efficiency of protein expression with Uaa incorporation can be improved by 
removing release factor 1 (RF1 for E. coli and eRF1 for eukaryotes). The decoding of the 
UAG amber codon normally competes with RF1, which leads to termination of protein 
synthesis and decreases protein yield. This issue has been dealt with in several ways. In 
one case, the Chin laboratory’s evolution of an orthogonal ribosome that no longer interacts 
with RF1 enables the efficient incorporation of a Uaa in response to amber codons at 
multiple sites.19-20 In a second example, it has been shown in some bacterial strains (such 
as E. coli C321) that the deletion of RF1 can improve the performance of Uaa incorporation 
in response to the quadruplet codon UAGA.21 This quadruplet system has been evolved 
from Methanocaldococcus jannaschii-derived frame-shift suppressor tRNA/RS pair that 
can enhance UAGN (N = any nucleotide) suppression efficiency. In eukaryotes, the release 
factor eRF1, which usually terminates the translation on all three stop codons, has been 
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engineered to provide a significant increase in Uaa incorporation in response to the UAG 
codon without increasing read-through of other stop codons.22 With the combination of this 
engineered eRF1 and an optimized PylRS/tRNA expression system for mammalian cells, 
one can increased the yield of protein containing a single site of Uaa substitution 17- to 20-
fold and the proteins yield for multiple site substitutions are comparable to a protein yields 
from a gene that does not contain a UAG stop codon. With these and other methods to 
improve protein yields, Uaa mutagenesis has become a robust technique that is being 
applied by an ever-growing number of laboratories.   
 
Analysis of Aminoacyl tRNA Synthetases (RSs) 
Since most UaaRSs are achieved through directed evolution as described above, 
there are a limited number of cases where detailed analysis of the structure and function of 
the resulting UaaRS have been performed. RSs catalyze a two-step reaction that provides 
aminoacylated tRNA for protein synthesis. The first step (1) involves the condensation of 
amino acid (Aa, or in this case, the Uaa) and ATP to form the enzyme-bound aminoacyl 
adenylate intermediate (Aa-AMP or Uaa-AMP) and release pyrophosphate (PPi). The 
second step (2) is the reaction between this adenylated intermediate and the 2’- or 3’-
terminal hydroxyl (OH) group on tRNA to form aminoacyl-tRNA (Aa-tRNA or Uaa-
tRNA). 
 
Aa + ATP    –>  Aa-AMP + PPi               (1)    
Aa-AMP + tRNA   –>  Aa-tRNA + AMP                 (2) 
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The ability of RSs to differentiate an amino acid substrate from other amino acids is almost 
solely responsible for the accuracy of protein synthesis.23 Indeed, it is the lack of ribosomal 
proof-reading of Uaa-tRNA that permits Uaa mutagenesis to work.  Thus, an analysis of 
the initial Uaa-AMP formation step can provide significant insight into UaaRS 
incorporation. In general, the analysis of RS function has mainly relied on steady state 
kinetic pyrophosphate exchange and aminoacylation assays.24 In the pyrophosphate 
exchange reaction, the RS is added to the reaction buffer containing amino acid, Mg•ATP, 
and [32P]-pyrophosphate in prepared reaction buffer. The [32P]-ATP formed is then 
adsorbed on activated charcoal or thin layer chromatography support. The standard 
pyrophosphate exchange assay is typically performed at 37 °C in a reaction containing [32P] 
Na•PPi, RS, amino acid in concentrations ranging from 0.2 to 10 times the Michaelis 
constant (Km), and ATP. The PPi exchange reaction is usually performed in the absence of 
tRNA. Therefore, the kcat and Km Michaelis-Menten values derived from this method are 
not necessarily identical to the actual rate of amino acid activation in the presence of tRNA. 
The steady-state tRNA aminoacylation reaction is traditionally investigated by monitoring 
the formation of [3H] or [14C] aa-tRNA over time. This steady-state assay is usually run at 
37 °C in buffer containing RS, amino acid, ATP, and tRNA. The limitation of the steady 
state aminoacylation assay is that amino acid concentrations are practically limited to 
concentrations of about 1 mM, due to the relatively low specific activity of [3H]- or [14C]-
labeled amino acids. Alternatively, the [32P]-labeled tRNA can be used together with 
unlabeled amino acid. 
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 Previous kinetic activities of RS charging of a few Uaas have been studied. For 
example, the Schultz group has analyzed the kinetics of adenylate formation of O-methyl 
tyrosine and tyrosine with ATP catalyzed by mutant TyrRSs using the pyrophosphate 
exchange assay. The Km value for tyrosine (5833 ± 902 µM) is approximately 13-fold 
higher than that for O-methyl-L-tyrosine (443 ± 93 µM). The kcat for tyrosine (1.8 ± 0.2 x 
10-3 s-1) is eight-fold less than that for O-methyl-L-tyrosine (14 ± 1 x 10-3 s-1).25  
 
 
Figure 1.4 The active site of TyrRS and a mutant UaaRS evolved to incorporate o-Iodotyrosine. 
The amino acid-binding site of the wild-type TyrRS L-tyrosine (Top left), 37V195C TyrRS 3-iodo-
L-tyrosine (Top right), and 37V195C TyrRS L-tyrosine complexes (Bottom right). Bottom left: 
The structure of o-iodotyrosine (Oiy).26-27 
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To alter the amino acid specificity of the orthogonal TyrRS so that it can charge the 
mutRNATyrCUA with a desired unnatural amino acid, a library of TyrRS mutants was 
generated and screened. Based on the crystal structure of the homologous TyrRS (Figure 
1.4) from Bacillus stearothermophilus, five residues in the active site of M. jannaschii 
TyrRS that are within 6.5 Å of the para position of the aryl ring of bound tyrosine were 
mutated.  Crystal structures of the corresponding evolved synthetases can be used to 
rationalize how specificity was changed. 
Kamtekar et al.28 reported the 3.2-Å resolution crystal structure of the 
Methanococcus maripaludis phosphoseryl-tRNA synthetases (SepRSs). The kinetic 
constants of these M. Maripaludis SepRS mutants for phosphoserine charging activation 
has measured by ATP-PPi exchange assay. Umehara et al. reported the directed evolution 
of PylRS from Methanosarcina mazei to generate N-acetyl lysyl-tRNA synthetases 
(AcKRSs). The kinetic activity of these AcKRSs has also been determined by ATP-PPi 
exchange assays.29 Limited structural information is available for PylRSs.30 
 
Genetic Incorporation of Fluorescent Amino Acids 
Genetically encoded fluorescent Uaas have been used to label proteins in both 
prokaryotes and eukaryotes, but the number of fluorescent Uaas developed is surprisingly 
small, given the noteable advantages of Uaa labeling: it provides perfect site-specificity 
and minimal perturbation of protein structure and function.  Schultz and coworkers 
reported the generation of an orthogonal RS/tRNA pair that selectively incorporates 7-
hydroxycoumarin amino acid (Hco) into proteins in E.coli.31 Hco has interesting properties 
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including a high fluorescence quantum yield (0.63), a large Stoke’s shift, small size, and 
sensitivity to pH and solvent polarity. The incorporation of Hco into proteins was carried 
out by using an evolved MjTyrRS/tRNA pair. Protein expression was shown in sperm 
whale myoglobin and protein mutants were used as a probe to study urea-induced chemical 
denaturation of holomyoglobin. The fluorescence intensity of the hydroxycoumarin moiety 
is sensitive to solvent polarity, and it showed correlation between protein unfolding and an 
increase in fluorescence of Hco. Hco has also been site-specifically incorporated into signal 
transducer and activator of transcription 3 (STAT3) in order to use the labeled protein as a 
fluorescent reporter of the phosphorylation status of STAT3.32 Hco was genetically 
incorporated into the STAT3b isoform in E. coli at Trp residue 564. A large fluorescence 
change was observed when the STAT3 probe was phosphorylated by Src kinase in vitro 
and when it was incubated with endogenously activated STAT3. This method enables the 
investigation of protein phosphorylation on other STAT protein substrates and other SH2 
domain-containing proteins because Trp564 is conserved in all seven mammalian STAT 
proteins. It also illustrates a general strategy for using fluorescent Uaas to make sensor 
proteins. 
Lou et al. reported the site-specific incorporation of three new coumarin lysine 
derivatives (Figure 1.5) into proteins in bacterial and mammalian cells using an engineered 
PylRS. The genetically encoded coumarin lysines were utilized as optochemical probes for 
protein localization and light activation of protein function in live cells.33  
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Figure 1.5 Structure of 7-hydroxycoumarin (1, Hco) and three coumarin lysine analogues (2-4) 
 
These three new coumarin lysine derivatives showed unique photochemical 
activities. Bromine atom substitution at the 6-position of 3 enables decaging not only with 
UV, but also near IR excitation using two photon methods. The extension of the linker 
chain in 4 can prohibit photolysis. Therefore, coumarin lysines 2 and 3 can be used as both 
fluorescent and light-activated probes for optochemical control of protein function using 
UV or near-IR light, while coumarin lysine 4 serves as a stable fluorescent probe that does 
not decage under UV excitation. To demonstrate the application of these coumarin lysines 
for optical control, photoregulation of firefly luciferase was achieved in live cells by caging 
a lysine residue, and excellent turn-on ratios were observed for 2 and 3. As expected, the 
stable coumarin amino acid 4 did not undergo photolysis. Furthermore, two-photon and 
single-photon excitation of EGFP tagged with 4 was also demonstrated by using different 
excitation wavelengths (365, 405, and 760 nm) for the sequential activation of protein 
function in live cells. While caged lysine 3 could be activated using two-photon irradiation 
at 760 nm, lysine 2 was stable under these conditions but could be decaged with blue light 
of 405 nm. This example illustrates how the long lysine linker allows one to attach 
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substrates of varying bulk and yet remain compatible with PylRS charging for protein 
incorporation. 
Schultz reported the site-specific incorporation of a second fluorophore, L-3-(2-
naphthyl)alanine (5, NAP), shown in Figure 1.6, into proteins in E. coli using M. 
jannaschii TyrRS mutants.34 A mutant of mouse dihydrofolate reductase containing NAP 
at Tyr163 was generated and characterized to confirm the ability of the NAPRS/tRNA pair 
to site-specifically incorporate NAP in response to an amber stop codon. 
Lee et al. reported the incorporation of 3-(6-acetylnaphthalen-2-ylamino)-2- 
aminopropanoic acid (6, Anap) into proteins using an orthogonal RS/tRNA pair derived 
from the E.coli LeuRS and engineered in a two-step process for the bulky Uaa (Figure 
1.6). Anap has absorption and emission maxima at 360 and 490 nm, respectively. Its 
extinction coefficient is 17,500 cm-1 M-1 and its quantum yield is 0.48 in EtOH (with 
excitation at 360 nm). The Anap amino acid was site-specifically incorporated in E. coli 
glutamine-binding protein and it was used to probe ligand-induced local conformational 
changes in proteins through solvatochromic effects without the need for a FRET pair. The 
small size of Anap and ability to introduce it by simple mutagenesis at defined sites should 
make it a useful probe of protein structure, molecular interactions, protein folding, and 
localization.35  
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Figure 1.6 Structure of NAP, Anap, danLys, dansylalanine, and terphenyl amino acids. (5-9) 
 
Chatterjee and Schultz also demonstrated the incorporation of Anap in mammalian 
cells in response to the TAG codon with high efficiency using AnapRS for expression of 
enhanced green fluorescent protein (EGFP) with an Anap mutation at a permissive site 
(Tyr40TAG) and a C-terminal histidine tag into Human Embryonic Kidney 293 (HEK293) 
or Chinese Hamster Ovary (CHO) cells.36 They further demonstrated that Anap can be used 
to image the subcellular localization of proteins in live mammalian cells by using confocal 
microscopy. Anap fluorescence was localized in the nucleus of histone H3. In addition to 
conventional fluorescence microscopy, Anap fluorescence can also be visualized by two-
photon excitation, which provides deeper tissue penetration, efficient light detection, and 
reduced phototoxicity. Two-photon excitation of the Anap-mCherry double-labeled 
histone H3 revealed excellent overlap between Anap (excitation, 730 nm, two-photon; 
emission, 420−500 nm) and mCherry (excitation, 543 nm; emission, 600−700 nm) 
fluorescence in the nucleus.  
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 Anap has also been used as a FRET pair in mammalian cells. Chatterjee and 
coworkers developed a genetically encoded FRET that uses Anap as the donor fluorophore 
and enhanced green fluorescent protein (EGFP) as the acceptor.37 They co-expressed the 
EGFP- Y39TAG mutant in HEK293T human embryonic kidney cells along with an 
orthogonal AnapRS/tRNA pair. This expression system can efficiently perform with Anap 
concentrations as low as 1 µM in the media. The calculate Förster radius of the Anap-EGFP 
FRET pair is 49 Å. They demonstrated the use of this FRET pair to monitor proteolysis 
reactions and protein conformational change in the Ca2+-dependent binding of the 
calmodulin protein to its substrate peptide M13. 
Another application of the Anap fluorophore is that it can be used to incorporate in 
the Shaker voltage-gated potassium channel (KV) at key regions that were previously 
inaccessible to labeling, and it can be used to study dynamic structural information 
collected from the cytosolic side of the channel which was not possible with the other 
chemical labeling method because of the large number of unwanted binding sites in the 
cytosol.38 
 The dansyl fluorophore has been shown to be ribosomally incorporated into b-
galactosidase by Chamberlin. e-Dansyllysine 7 (e-DanLys) along with the other two 
fluorescent amino acids; 5-hydroxytryptophan, 7-azatryptophan, have been site-
specifically incorporated in vivo using chemically charged tRNAs (note that this method 
has not been discussed above due it slack of adoptability by other laboratories in 
comparison to the UaaRS methods).39 
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 The fluorescent unnatural amino acid 2-amino-3-(5-(dimethylamino)naphthalene-
1-sulfonamide)propanoic acid (8, Dansylalanine) was genetically encoded in 
Saccharomyces cerevisiae with high fidelity and good yield using an orthogonal RS/tRNA 
pair.40 This environmentally sensitive fluorophore was selectively inserted into human 
superoxide dismutase and used to monitor unfolding process in the presence of 
guanidinium chloride. 
Lei Wang also reported the incorporation of dansylalanine 8 into a voltage-
dependent membrane lipid phosphatase, specifically the voltage-sensitive domain (VSD) 
of Ciona intestinalis voltage-sensitive phosphatase (CiVSP). They described a lentiviral-
based gene delivery method to stably incorporate Uaas into proteins expressed in HCN-
A94 neural stem cells. This genetically encoded fluorescent Uaa optically reported on the 
conformational change of the voltage-sensitive domain in response to membrane 
depolarization in differentiated neurons.41 
The incorporation of fluorescent unnatural amino acid 4-biphenyl-L-phenyl alanine 
(9, Terphenyl) in Figure 1.6 into GFP has been achieved by Douglas Young and 
coworkers.42 Terphenyl moieties have relatively high quantum yields (f = 0.49), long 
fluorescent lifetimes (t = 4.38 ns) and novel emission spectra with large Stokes shifts (lex/ 
lem = 280/342 nm). This terphenyl moiety has also been found to be environmentally 
sensitive and widely used in various applications including two-photon laser scanning 
microscopy, femtosecond fluorescence spectroscopy, and a-helical secondary structure 
investigations. Previously, Sidney Hecht’s group demonstrated that various terphenyl 
derivatives could be incorporated into dihydrofolate reductase from E. coli for FRET 
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studies by using chemically acylated tRNA methods.43-44 The terphenyl amino acid has 
been shown by Young to be site-specifically incorporated into GFP at multiple sites and 
these GFP mutants has been shown to impact the protonation state of the terphenyl 
fluorophore, potentially expanding the utility of the protein as a biosensor.42  Together, 
these studies illustrate the wide array of potential applications of fluorescent amino acids. 
  
Fluorescent Labeling Using Unnatural Amino Acids with Bioorthogonal Reactivity 
An alternative approach for protein labelling can be performed by site-specific 
incorporation of Uaas with “biorthogonal” handles into proteins by genetic code expansion 
followed by subsequent labeling of these proteins by specific chemoselective reactions. 
(Figure 1.7a) These biorthogonal reactions need to proceed under 
biologically/physiologically compatible conditions and yet react only with the desired 
partner and not any of the endogenous biomolecule functional groups. Several examples 
of these reactions have been shown including reaction of ketones/aldehydes with 
hydrazines/hydroxylamines, the classic copper-catalyzed azide-alkyne cycloaddition 
reaction (CuAAC), the strain-promoted azide-alkyne cycloaddition reaction (SPAAC), 
Staudinger ligations, certain palladium-catalyzed cross-coupling reactions, “photoclick” 
reactions, inverse-electron-demand Diels-Alder reactions.17 These chemoselective 
reactions usually have rate constant in the order of 10-4 – 104 M-1 s-1 as shown in Figure 
1.7b. 
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Figure 1.7 Labeling proteins via incorporation of unnatural amino acids that can be 
chemoselectively labeled. (a) An unnatural amino acid bearing a unique bioorthogonal 
functionality is introduced site-specifically into a protein via genetic code expansion and then 
chemoselectively labeled with an externally added chemical probe. (b) Rate constants of 
chemoselective reactions for which one of the partners can be genetically encoded in form of an 
unnatural amino acid. (Adapted figure reproduces from Lang, K., Chin, J.W. Cellular Incorporation 
of Unnatural Amino Acids and Bioorthogonal Labeling of Proteins, Chem. Rev. 2014, 114, 
4764−4806.) 
 
 While Uaas containing bioorthogonal amino acids can be used to install a wide 
variety of fluorophores, there can be some limitations of the utility of these probes in 
studying protein folding.  Direct genetic encoding of a fluorescent Uaa allows one to place 
a chromophore on the interior of a protein and to label proteins that cannot be reversibly 
unfolded and refolded. Having the chromophore attached by a short sidechain rather than 
a “click” chemistry linker also reduces the positional uncertainty of the FRET probe.  For 
example, in the example of measuring FRET between two probes attached to the protein 
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a-synuclein (Figure 1.8), commonly used linkers would lead to a 30 Å variance in the 
distance between the probes.  Thus, our work has focused on small fluorophores, relatively 
closely tied to the protein backbone (unlike Lys derivatives 2-4 or 7) and with rationally 
tunable fluorescent properties (unlike NAP and Anap). 
 
Figure 1.8 Effects of flexible linkers on the range of chromophore distances in a FRET experiment. 
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Acridone as a Tunable Fluorescent Scaffold for Generating Fluorescent Amino 
Acids 
The research described in this thesis builds off of previous experiments in which 
the amino acid acridonylalanine (Acd, Figure 1.9) was shown to be a genetically 
incorporable fluorescent Uaa.  This was initially demonstrated by Sisido and coworkers 
using in vitro translation of chemically aminoacylated tRNA.45  Subsequently, our 
laboratory collaborated with Ryan Mehl to develop an RS-based system for Acd 
incorporation.46  However, this AcdRS was prone to misincorporation of a trace byproduct 
of the Acd synthesis, and thus Chapter 2 describes its optimization.  These optimization 
efforts included collaborations with the Saven laboratory to computationally model 
different generations of AcdRS resulting from directed evolution experiments, as well as 
analysis of purified versions of the RSs, using established methods which are briefly 
described above.  While Acd is a valuable blue fluorescent amino acid, many aspects can 
be improved, including its brightness and modifying its absorption and emission to make 
red-shifted variants.  Thus, Chapter 3 describes these efforts, resulting in 
aminoacridoylalanine (Aad, Figure 1.9).  To arrive at Aad, a series of analogs of the 
acridone core were prepared and analyzed using photophysical techniques.  These data 
were also compared to calculations performed by George Petersson which showed 
excellent correlation with the experimental data, making us optimistic about predicting Acd 
derivatives in the future.  Finally, Chapter 4 describes ongoing efforts to improve the 
synthesis of Aad and rationally modulate its fluorescence to increase its brightness. 
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Figure 1.9 The structure of acridonylalanine (Acd) and 2-aminoacridonylalanine (Aad) 
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CHAPTER  2 : The Optimization of a Permissive Aminoacyl tRNA Synthetase for a 
Target Unnatural Amino Acid 
 
 
 
Adapted with permission from Sungwienwong, I.; Hostetler, Z. M.; Blizzard, R. J.; 
Porter, J. J.; Driggers, C. M.; Mbengi, L. Z.; Villegas, J. A.; Speight, L. C.; Saven, J. G.; 
Perona, J. J.; Kohli, R. M.; Mehl, R. A.; Petersson, E. J., Improving target amino acid 
selectivity in a permissive aminoacyl tRNA synthetase through counter-selection. Org. 
Biomol. Chem. 2017, 15, 3603-3610. Copyright (2017) Royal Society of Chemistry. 
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Background 
 It is now well-established that protein folding and dynamics play essential roles in 
health and disease. For example, the small protein calmodulin (CaM) undergoes a dramatic 
conformational rearrangement to carry out its calcium sensor function in eukaryotic 
cells.47-48 In a second example, the bacterial repressor-protease LexA uses a complex 
sequence of RecA-induced structural change, self-proteolysis, and dissociation of subunits 
to sense DNA damage and activate genes that ultimately lead to antibiotic resistance.49-50 
Finally, the conformational flexibility of the neuronal protein a-synuclein (aS) is a 
liability, as it leads aS to misfold and form amyloid fibrils that contribute to the 
pathogenesis of Parkinson’s disease.51-52 Fluorescence spectroscopy is a powerful tool for 
studying such processes, as it allows one to observe protein motions in real time under 
physiological conditions, including measurements in live cells.53-54 One can even obtain 
low resolution structural information using distance-dependent chromophore interactions 
such as Förster resonance energy transfer (FRET) and quenching by photo-induced 
electron transfer (eT).9 To appropriately model protein motions, one needs a set of probes 
that are capable of accurately reporting on distance changes without disrupting the fold and 
function of the protein of interest.8 
Recent developments in genetic code expansion and biorthogonal chemistry have 
made the site-specific incorporation of unnatural amino acids (Uaas) and installation of 
fluorophores through post-translational modification straightforward, even in cells or 
lysates.17 Unfortunately, the fluorophores used in these approaches are often relatively 
large and are attached by long flexible linkers, which have a non-trivial impact on the 
  
 
26 
observed FRET measurements.  Additionally, larger fluorophores cannot be introduced co-
translationally to allow packing into the interior of a folded protein.  Thus, they will be 
restricted to surface-accessible positions, limiting the regions of the protein for which 
conformational changes can be studied. 
Smaller probes that are more closely tied to the backbone are better able to report 
on conformational changes of the protein.  The Petersson laboratory has developed small 
fluorescent probes and quenchers that should be non-perturbing to proteins and which are 
closely tied to the protein backbone.  These include thioamide substitutions of the backbone 
itself and intrinsically fluorescent Uaas such as acridon-2-ylalanine (Acd or 1).46 These 
new approaches are significant because, of the >100 Uaas that have been genetically 
encoded in E. coli, only four are fluorescent. 18, 31, 35-36, 40, 46, 55-56  
 Acd is a blue-wavelength fluorescent amino acid that is a useful fluorophore 
because of its small size (222 Å3), near unity quantum yield in water (F = 0.95), unusually 
long lifetime (t ~ 15 ns) and high photostability (< 5% degradation after 3 h irradiation).45, 
57-58 Previous work in the Petersson laboratory has shown that Acd can be efficiently 
quenched by a thioamide through an eT mechanism.59 We have also shown that it can be a 
valuable FRET acceptor from Trp or methoxycoumarin, and a donor to more red-shifted 
dyes such as nitrobenzoxadiazole (NBD) or fluorescein.46  
Prior to our work, Sisido and coworkers had shown that Acd can be ribosomally 
incorporated into proteins by in vitro translation using the PURE system.  Since protein 
yields from this system can be quite low due to its small scale, the Mehl and Petersson 
laboratories developed an in vivo system for Acd incorporation using methods pioneered 
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by Schultz.10  These methods require the generation of an aminoacyl tRNA synthetase (RS) 
that is selective for the Uaa and a tRNA that can be selectively charged by the ncRS to 
deliver the tRNA to an unassigned codon, typically the amber stop codon UAG 
(tRNACUA).27 An RS was selected from a library of permissive M. janaschii (Mj) tyrosyl 
RS mutants that had previously been shown to incorporate bulky aromatic amino acids 
such as 4-(2′-bromoisobutyramido) phenylalanine (Brb) and p-benzoyl phenylalanine 
(Bzf).60-62 The most active mutant from this library (G2) was used to express Acd-
containing variants of CaM, triose phosphate isomerase, and aS.46  Here, we will refer to 
this mutant as AcdRS1. 
Previous Acd syntheses reported by Lankiewicz and Sisido used a NaOH 
deprotection step and acid-catalyzed Friedel-Crafts cyclization in polyphosphoric acid 
(PPA). However, the yields from this route were only 23% from the p-nitrophenylalanine 
starting material, and even this material presumably had substantial racemization due to 
hydroxide treatment.  We improved the synthesis by starting from the natural amino acid 
Tyr (2) using a Buchwald-Hartwig coupling to O-methyl anthranilate (4) to form 5. 
(Scheme 2.1)46 We also found heating in sulfuric acid with the addition of water to be a 
preferable way to induce Friedel-Crafts cyclization, as it resulted in deprotection of the Boc 
group and methyl esters as well.  We obtained an 86% overall yield from Tyr using the 
route shown in Scheme 2.1 with H2SO4 used in the final step (no racemization observed 
by high performance liquid chromatography, HPLC).  Unfortunately, this route also 
produced a decarbonylated by-product, N-phenyl-aminophenylalanine (Npf or 6) in trace 
amounts.  We found that Npf was in fact incorporated much more efficiently by AcdRS1 
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than Acd.  Thus, although Npf was present at < 1% according to HPLC analysis, roughly 
50 % of the expressed protein contained Npf.  
  We were able to initially address this problem by converting 5 to Acd using 
LiOH deprotection followed by PPA cyclization.  This eliminated Npf formation, 
but limited us to a 44% overall yield from Tyr with complete racemization (a 22% 
yield of the requisite L-Acd form).  While we were able to express proteins 
containing exclusively Acd, this was not a very satisfactory solution, and we sought 
to obtain an AcdRS that was sufficiently selective against Npf that we could use the 
higher yielding H2SO4 synthetic route.  We also recognized that the paradigm of 
using a permissive RS library to obtain an initial, working RS and subsequently 
optimizing it for a target amino acid would be a strategy that could be employed by 
other laboratories if we were successful. 
 
  
 
 
 
 
 
 
 
 
Scheme 2.1 The synthesis of acridon-2-ylalanine (Acd). 
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Synthetase Selection 
  A typical selection experiment to evolve an RS for a Uaa consists of rounds 
of positive selection (performed in the presence of the Uaa and the 20 canonical 
amino acids) and negative selection (performed in the presence of only the 20 
canonical amino acids).  To develop an AcdRS specific for Acd only, we performed 
these standard selections as well as negative selections where Npf was included in 
the selection media to eliminate those AcdRS mutants charging tRNA with Npf.  
This resulted in two additional RSs, AcdRS2a (clone G11, from traditional negative 
selection) and AcdRS2b (clone A9, from Npf counter-selection), which both showed 
good selectivity in an initial screen in which the Uaas were incorporated into green 
fluorescent protein (GFP). 
  We have performed detailed studies of their in vivo selectivities in 
expressions of CaM, aS, and LexA and found that AcdRS2b has superior selectivity 
for Acd when compared to AcdRS2a.  We have also expressed and purified AcdRS1 
and AcdRS2b to measure their Acd and Npf activation kinetics.  We are able to 
rationalize their selectivities in terms of the X-ray crystal structure of AcdRS1 and 
a homology model of AcdRS2b.  Our study provides an improved Acd incorporation 
method for fluorescent labeling of proteins, and also validates a general strategy for 
how one may optimize a permissive RS to eliminate incorporation of an unwanted 
contaminant. 
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Figure 2.1 AcdRS selection. Left: Images of E. coli agar plates used in rounds of positive (+ Acd) 
and negative (+ Npf) selection.  Media for both plates also contain sources of the 20 canonical 
amino acids.  Middle: Fluorescence of suspensions of E. coli cells expressing GFP with a TAG 
codon at position 150 using the indicated RS clone and amino acid mixture.  Emission was 
measured at 528 nm with excitation at 485 nm.  Top Right: Image of the AcdRS1 (G2) active site 
with radical polymerization initiator Brb bound. (PDB ID: 4PBR)  A favourable hydrogen bond 
between the carboxylate of Glu65 and the aniline N-H of Brb can be seen.  Bottom Right: Sequences 
of Mj RS clones used for incorporation of Acd.  Additional sequences of clones from GFP-based 
screening are given in the experimental method section (Figure 2.6 and Table 2.2). 
 
  CaM, LexA and aS constructs with UAG mutations were expressed in E. coli 
along with plasmids encoding AcdRS1 and its cognate tRNACUA species.  We 
analyzed the selectivity of AcdRS1 based on matrix-assisted laser desorption 
ionization (MALDI) mass spectrometry (MS) data of both intact and trypsin-
digested, purified proteins, including CaM, LexA, and aS.  Data for incorporation 
at position 113 in CaM are shown in Figure 2.2, 2.3, and 2.7; additional data for αS 
and LexA are shown in Figure 2.8 and 2.9, respectively.  In all cases, when the 
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proteins are expressed using media containing pure Npf or Acd produced using the 
PPA route, a single peak for the intended product is obtained in the MALDI spectra.  
When the proteins are expressed in media containing Acd produced using the H2SO4 
route, we observe a roughly 45:55 Npf/Acd ratio of the two CaM species, even 
though Npf is present only in trace quantities.  We also considered the possibility 
that Npf could be generated in vivo by several possible routes.  For example, a 
carboxy-lyase suchas YigC could convert 7 (also a < 1% contaminant in the H2SO4 
Acd synthesis) into Npf,63 or some fraction of Acd could be converted to Npf.  Our 
PPA Acd expression data allow us to exclude metabolic processing of Acd, since 
we see no Npf incorporation in this case.  When we use media in which we 
intentionally include 1% or 10% Npf with Acd, we detect products containing 
Npf/Acd ratios of 65:35 and > 95:5, respectively. (Figure 2.8)  These data and 
similar data for other proteins indicated to us that the selectivity of our nominal 
AcdRS—designed to incorporate Acd specifically—in fact favored Npf 
incorporation by approximately 100-fold.  Despite the incongruity between its 
intended use and its actual fidelity, one should keep in mind that AcdRS1 was 
selected based on expression yields of GFP in the presence of media containing Acd 
from the H2SO4 route (and therefore containing ~1% Npf).  Similar contamination, 
barely detectable by HPLC analysis, may be present in other stocks of home-
synthesized or commercial batches of Uaas used in RS selection. 
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AcdRS Optimization 
RS Selection to Remove Npf Activity.  
(Note: Synthetases selection experiments were performed by Robert J. Blizzard, 
Joseph J. Porter, and Professor Ryan A. Mehl at Department of Biochemistry and 
Biophysics, Oregon State University) 
  To reduce the incorporation of Npf, we screened mutant Mj TyrRS libraries 
with positions in the amino acid binding pocket randomized using a GFP expression 
screen common to the Mehl laboratory.61, 64  Two rounds of positive and negative 
selection were performed according to standard protocols, with the desired Uaa (i.e., 
Acd) present in the media for rounds of positive selection and only the 20 canonical 
amino acids present in the media for rounds of negative selection.  In parallel, we 
also performed a similar two round selection experiment with a novel negative 
selection step that included the undesired Npf in the media.  Thus, in this second 
“counter-selection” protocol, we explicitly selected against Npf incorporation rather 
than relying on high activity for Acd to be mutually exclusive of activity for Npf.  
The Mj RS libraries were based around the G2 (AcdRS1) and F9 clones, both of 
which incorporate Acd, and have very similar sequences.  The level of Npf 
misincorporation is noticeably higher for F9 than for G2, highlighting the idea that 
small sequence changes can have a large impact on selectivity. 
  From these two selection protocols, eleven RS clones were identified that 
showed high levels of Acd incorporation.  Of these clones, only A9 derived from 
the Npf counter-selection.  Among the ten clones from the standard negative 
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selection, the G11 clone demonstrated the highest level of selectivity as measured 
by the GFP fluorescence of cell suspensions expressed in media containing either 1 
mM Acd or 1 mM Npf. (Figure 2.1 and 2.6)  Therefore, the G11 and A9 RSs were 
cloned into the pDule2 vector for expression of other proteins, and are referred to as 
AcdRS2a and AcdRS2b, respectively. 
 
Comparison of AcdRS Active Sites.  
  The availability of an X-ray crystal structure of AcdRS1 (G2) allowed us to 
examine the sequences of various library members to understand how changes might 
confer increased selectivity for Acd relative to Npf.  Although we were never able 
to obtain suitably diffracting crystals of an Acd complex with AcdRS1, the Mehl 
group has previously published a structure of this RS with Brb bound. (Figure 2.1, 
Top right)  Recall that “AcdRS1” is a permissive RS, as can be seen in an analysis 
of its activation of a variety of aromatic Uaas in Cooley et al.64 Brb, Npf, and Acd 
share the feature of a nitrogen atom in the para position of the phenylalanine ring, 
which seems to be a key recognition determinant as it can hydrogen bond with Glu65.  
Both of the RS clones that give the highest selectivity for Acd, AcdRS2a (G11) and 
AcdRS2b (A9), have a mutation at this position, but one that maintains the potential 
hydrogen bond acceptor functionality.  Other library members with Pro, Trp, Ile, or 
Val at position 65 had less than ten-fold selectivity for Acd over Npf in the GFP 
assay. (See experimental method section for details)  Further analysis of AcdRS1 
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(G2), AcdRS2a (G11), and AcdRS2b (A9) selectivity based on homology modelling 
and docking studies is given below. 
 
Analysis of AcdRS Selectivity 
In Vivo Characterization of AcdRS Selectivity.  
  To more rigorously investigate the selectivity of AcdRSs 2a and 2b, we 
expressed proteins in E. coli, purified them, and analyzed incorporation by MALDI 
MS of whole proteins and trypsin digests.  As above, each experiment was carried 
out under five media conditions, varying in the amino acid provided and/or the 
synthetic route by which it was obtained: with H2SO4 Acd, PPA Acd, Npf, 1% 
Npf/Acd, and 10% Npf/Acd.  Data for incorporation at position 113 in CaM are 
shown in Figure 2.2 and Figure 2.3; data for aS and LexA are shown in the Figure 
2.8 and Figure 2.9.  As anticipated from the GFP screening data, we found that both 
AcdRS2a and 2b have improved selectivity against Npf.  However, AcdRS2a still 
gives a mixture of Npf- and Acd-containing protein when H2SO4 Acd is used in the 
growth media.  In contrast, proteins expressed using AcdRS2b contain only Acd, 
even when challenged with 10% Npf in the media.  This level of selectivity was 
observed in CaM, aS, and LexA. (Figure 2.2 and Figures 2.7 – 2.9)  It should also 
be noted that AcdRS2b selectivity is observed in a variety of media.  CaM and aS 
are expressed in minimal media or Luria broth (LB) with isopropyl β-D-1-
thiogalactopyranoside (IPTG) induction, while LexA is expressed in richer, 
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arabinose auto-induction media.  Based on these data, we selected the AcdRS2b 
(A9) for further characterization 
 
 
 
Figure 2.2 In vivo AcdRS selectivity.  CaM (UAG codon at 113) was expressed in minimal 
media containing 1 mM Uaa: Acd, synthesized either using the H2SO4 route or PPA route, 
or Npf.  Expression was performed with one of the three AcdRSs indicated.  Significant 
incorporation of Npf is seen for AcdRS2a (G11) when using H2SO4 Acd, but only Acd-
containing protein is seen with AcdRS2b (A9). 
 
   
  For a more rigorous, quantitative analysis of selectivity, we analyzed the 
CaM trypsin digest data by normalizing the intensity of the peak for the 108-116 
fragment, containing Acd or Npf at position 113, to the intensity of the peak for the 
117-127 fragment. (Figure 2.3)  CaM117-127 should be produced in a 1:1 ratio with 
CaM108-116 when the protein is completely digested by trypsin, and this can be 
confirmed by varying the digest time and observing that the intensity ratios do not 
change (data not shown).  Normalization using an internal standard is essential to 
interpreting the intensity data correctly.  The CaM108-116Acd113 fragment (A in 
Figure 2.3) ionizes 5.5-fold better than the CaM117-127 fragment (* in Figure 2.3), 
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while the CaM108-116Npf113 fragment (N in Figure 2.3) ionizes 6.1-fold worse than 
the CaM117-127 fragment.  This can be seen by examining the peak ratios for PPA 
Acd (i.e., Acd only) and Npf expressions.  After peak scaling, one obtains an MS-
based Acd/Npf selectivity ratio (MS Sel) of 2.6 X 10-3 for AcdRS1 and 0.20 for 
AcdRS2b, calculated as follows: 
 
MS Sel = (Scaled Acd/ Scaled Npf)/(Acd/Npf ratio in media) 
 
  The AcdRS1 MS Sel value is in good agreement with our estimate of 100-
fold selectivity for Npf based on the less quantitative whole protein MALDI MS 
data.  While the AcdRS2b MS Sel value may seem surprisingly low given the 
absence of any obvious CaM108-116Npf113 peak in the MALDI spectra, it is important 
to keep in mind that the RS is only being challenged with at most 10% Npf in the 
media and that CaM108-116Npf113 ionizes 30-fold worse than CaM108-116Acd113.  
Using these Acd/Npf selectivity ratios, we determined that selection resulted in a 
76-fold improvement in selectivity for AcdRS2b relative to AcdRS1.  We note that 
the effective in vivo Acd selectivities for both AcdRS1 and AcdRS2b are less than 
one and are probably influenced by preferential uptake of Npf into cells. 
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Figure 2.3 CaM113 trypsin digest data for AcdRS selectivity analysis.  CaM (UAG codon at 113) 
was expressed in minimal media containing 1 mM Uaa: Acd, synthesized either using the H2SO4 
route or PPA route, Npf, or either a 99:1 or 90:10 mixture of PPA Acd and Npf.  Expression was 
performed with one of the three AcdRSs indicated.  The peaks for the (M+H)+ masses of the 
CaM108-116Acd113 fragment (A, 1179.8 Da), CaM108-116Npf113 fragment (N, 1153.8 Da), and  CaM117-
127 fragment (*, 1349.9 Da) are indicated.  The intensities of the CaM108-116Acd113 and CaM108-
116Npf113 fragment peaks were normalized using the intensity of the CaM117-127 fragment peak. 
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In Vitro Characterization of RS Activity.   
  To better understand AcdRS1 and 2b selectivity, we generated His-tagged 
variants of the enzymes, then expressed and purified them for in vitro activity assays.  
Charging of tRNA by RSs is a two-step process, where the first step is the RS-
catalyzed reaction of amino acid with ATP to form an aminoacyl-adenylate 
intermediate (Aa-AMP), releasing inorganic pyrophosphate (PPi); and the second 
step is the reaction of this enzyme-bound adenylate with the 2’ or 3’ hydroxyl group 
on A76 at the 3’ end of the tRNA.65  
 
Aa + ATP    –>  Aa-AMP + PPi               (1)    
Aa-AMP + tRNA   –>  Aa-tRNA + AMP                 (2) 
 
  While some prior studies have used assays that measure only the first step of 
the aminoacylation reaction to demonstrate that in vitro activities are consistent with 
Uaa incorporation,10, 66-67 it has been shown by the Perona laboratory that full tRNA 
aminoacylation assays correlate well with in vivo observations of RS activity.68  This 
is expected, since amino acid incorporation into protein in vivo can only occur upon 
aminoacylation. Thus, aminoacylation of an in vitro transcribed 32P-labeled 
tRNACUA was measured under single-turnover conditions at a variety of Acd or Npf 
concentrations for AcdRS1 and AcdRS2b.  Plots of the first-order rate constants as 
a function of amino acid concentration were used to determine kobs and Kd for each 
amino acid and RS combination, as previously described.69 (Figure 2.4 and Table 
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2.1)  For these measurements, kobs corresponds to the microscopic rate constant for 
the chemical steps of aminoacylation, or to a closely linked first-order rearrangement 
that follows tRNA binding and precedes aminoacylation. 
  Comparative kinetic analysis of AcdRS1 and AcdRS2a reveal catalytic 
preferences that correlate well with measurements of amino acid incorporation in 
vivo and mass spectrometry of proteins incorporating Acd and Npf.  AcdRS1 
aminoacylates tRNACUA with Acd three-fold slower than with Npf, while AcdRS2b 
aminoacylates tRNACUA with Acd five-fold faster than with Npf (Table 2.1).  These 
changes in kobs are primarily responsible for the change in selectivity between these 
two RSs, as there are only relatively minor differences in Kd for the amino acids.  
The enzymological selectivity (Enz Sel), calculated as  
 
Enz Sel = [kobs(Acd)/Kd(Acd)] / [kobs(Npf)/Kd(Npf)] 
 
changes from about a two-fold Npf preference by AcdRS1 to 16-fold Acd selectivity 
for AcdRS2b.  Overall, AcdRS2b is improved in selectivity for Acd relative to Npf 
by 34-fold, in reasonable agreement with the 76-fold specificity shift derived from 
the in vivo measurements made based on trypsin digest peak intensities.  Note that 
while the relative change in selectivity is consistent between the in vitro and in vivo 
data, the actual selectivities are quite different, presumably because the in vivo MS 
Sel is the product of Enz Sel and factors affecting the availabilities of the amino 
acids inside the cells.  We estimate that the effective Npf concentration in cells is 
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about 100-fold greater than the Acd concentration.  This could be the result of 
preferential uptake of Npf, or sequestration of Acd by binding to other targets.  Such 
targets could include DNA or RNA, both of which are known targets of acridone-
based intercalator molecules.70  Thus, to prevent Npf misincorporation, AcdRS2b 
must be significantly Acd-selective, even though Npf contaminants are only present 
at about 1% (10 µM) in the media. 
 
 
Figure 2.4 tRNA Aminoacylation kinetics.  Plot of kobs for reactions of AcdRS1 and AcdRS2b as 
a function of Acd or Npf concentration.  Reaction rates were determined using thin layer 
chromatography following nuclease digestion of aminoacylated tRNA as described in the ESI.  
Sample primary data are shown in Fig. 2.12  Rate constants were determined from progress curves 
for each enzyme at varying amino acid concentrations. 
(Note: These tRNA aminoacylation kinetic assays were tested by Professor John J. Perona 
at Portland State University) 
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Table 2.1 AcdRS In vitro enzymology and in vivo MS selectivity (Sel) parameters 
AcdRS kobs(Acd) 
x 10-3 s-1 
Kd(Acd) 
µM 
kobs(Npf) 
x 10-3 s-1 
Kd(Npf) 
µM 
Enz 
Sel 
MS 
Sel 
1 (G2) 8.0 
± 2.0 
45.1 
± 18.8 
24.0 
± 1.0 
64.1 
± 10.8 
0.47 2.6 x 10-3 
2b (A9) 28.0 
± 2.0 
39.9 
± 6.8 
5.0 
± 1.0 
~114 
± 10.0 
16 0.20 
 
 
Modeling of AcdRSs complexed with Npf and Acd.  
(Note: Modeling experiments were done by José A. Villegas and Professor Jeffery 
G. Saven at Department of Chemistry, University of Pennsylvania) 
  To inform the differences in Acd and Npf charging activity, models were 
built based upon the crystallographic structure of AcdRS1 complexed with Brb 
(PDB ID: 4PBR).64 In generating a model of AcdRS1 (G2), the phenyl ring on the 
Brb ligand guided the placement of Acd and Npf within the binding pocket.  
Hydrogen atoms were added to the protein, and the ligand structure was energy 
minimized within the fixed protein structure.  For Acd, a void volume remains 
between the molecule and the G32-G34 β-strand.  In each G2 complex, Glu65 is poised 
to accept a hydrogen-bond from the N-H of the ligand’s side chain.  For Npf, the 
additional free volume allows the molecule to relax to a twisted conformation, 
alleviating repulsive internal steric contacts between the ligand’s two phenyl rings. 
  Using the same protein structure, computational protein design methods 
developed in the Saven laboratory were used to generate a model of A9,71-74 
followed by energy minimization of the atomic coordinates of the ligands and the 
mutated side chains.  In A9, the Gly32Ala mutation forces Npf to adopt a more planar 
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conformation of the ligand’s two phenyl rings in order to form a hydrogen bond with 
Asp65.  Instead, Npf relaxes to avoid this high-energy distortion, which not only 
prevents hydrogen bonding of the Npf aniline N-H with Asp65, but also forces the 
Asp65 sidechain to move.  While it is possible that the actual conformations adopted 
in the active site are different in the presence of tRNA, these models are consistent 
with AcdRS2b’s increased activity toward Acd relative to Npf.  Thus, it appears that 
the combination of the Gly32Ala and Glu65Asp mutations provides the increase in 
Acd selectivity for AcdRS2b (A9). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.5 AcdRS homology models.  Acd or Npf were energy minimized in the active site 
of AcdRS1 (G2), taken directly from PDB structure file 4PBR, or a model of AcdRS2b 
(A9).  Npf is accommodated in the AcdRS1 active site where the phenyl rings can become 
non-planar with respect to each other.  In the A9 active site, Npf twisting is restricted by the 
Ala32 sidechain, and a hydrogen bond cannot be made with Asp65. 
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Conclusion 
  Our elucidation of the process by which trace Npf in the Acd media was 
incorporated into expressed proteins and our subsequent optimization of AcdRS1 
provide a cautionary tale to the field of genetic code expansion, as well as a 
potentially general solution to the problem.  Explicit inclusion of the unwanted Npf 
in the counter-selection step allowed us to obtain AcdRS2b, which had much higher 
selectivity toward its cognate Uaa than AcdRS2a, obtained through standard rounds 
of positive and negative selection (against only the 20 natural amino acids).  Trace 
contaminants in batches of Uaas, synthesized either in-house or bought from 
commercial vendors, may indeed be utilized by many RSs in the literature which 
have never been purposefully selected for or against charging of these Uaas.  
Moreover, variations of in vivo availability (resulting from differential uptake, for 
example) may exacerbate these problems, as appears to be the case with Npf. 
  Permissive RSs in libraries, which provide a very efficient way of obtaining 
RSs for new Uaas, are likely to be susceptible to this problem.  Indeed, RSs with 
open binding sites that accept bulky amino acids such as Acd and Brb may be 
particularly prone to this difficulty.  However, using such a permissive RS with an 
open pocket is sometimes necessary to finding an RS for an amino acid such as Acd.  
In some cases, RS selection for bulky Uaas has required an initial round of selection 
using a more moderate sized amino acid to expand the binding pocket before 
selection for charging of a bulky aromatic Uaa.35  Such RSs may be prone to 
misincorporation of amino acids similar to that intermediate amino acid.  Here, we 
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have seen that small sequence changes (i.e. Gly->Ala and Glu->Asp) can result in 
large increases in in vitro and in vivo selectivity for permissive RSs.  Thus, we expect 
that the counter-selection strategy used here will be generally useful to the genetic 
code expansion community. 
 
Experimental Methods 
General Information 
Materials  
L-Tyrosine, thionyl chloride, di-tert-butyl dicarbonate (Boc anhydride), methyl 2-
aminobenzoate, and phenylsepharose CL-4B resin were purchased from Sigma-Aldrich 
(St. Louis, MO, USA).  N-Phenyl-bis(trifluoromethane sulfonimide) was purchased from 
Oakwood Chemical (West Columbia, SC, USA).  E. coli BL21(DE3) cells were purchased 
from Stratagene (La Jolla, CA, USA).  E. coli ElectroMAX DH10B cells were purchased 
from Invitrogen (Grand Island, NY, USA).  Milli-Q filtered (18 MΩ) water was used for 
all solutions (Millipore; Billerica, MA, USA).  Bradford reagent assay kits were purchased 
from BioRAD (Hercules, CA, USA).  Amicon Ultra centrifugal filter units (3 kDa MWCO) 
were purchased from EMD Millipore.  All other reagents and solvents were purchased from 
Fisher Scientific or Sigma-Aldrich unless otherwise specified.  DNA sequencing was 
performed at the University of Pennsylvania DNA sequencing facility. 
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Instruments 
Low resolution electrospray ionization mass spectra (ESI-LRMS) were obtained on 
a Waters Acquity Ultra Performance LC connected to a single quadrupole detector (SQD) 
mass spectrometer.  UV-Vis absorption spectra were acquired on a Hewlett-Packard 8452A 
diode array spectrophotometer (currently Agilent Technologies; Santa Clara, CA, USA).  
Nuclear magnetic resonance (NMR) spectra were obtained on a Bruker DRX 500 MHz 
instrument (Billerica, MA, USA).  Matrix assisted laser desorption/ionization with time-
of-flight detector (MALDI-TOF) mass spectra were acquired on a Bruker Ultraflex III 
instrument.  Analytical HPLC was performed on an Agilent 1100 Series HPLC system. 
Preparative HPLC was performed on a Varian Prostar HPLC system (currently Agilent 
Technologies). HPLC columns were purchased from W. R. Grace & Compnay (Columbia, 
MD, USA). 
 
Chemical synthesis of acridon-2-ylalanine (Acd) 
Methyl (S)-2-((tert-butoxycarbonyl)amino)-3-(4-(((trifluoromethyl)sulfonyl)oxy) 
phenyl) propanoate (Boc-L-Tyr(OTf)-OMe, 3). L-Tyrosine (2) (5.07 g, 27.99 mmol) 
was reacted with SOCl2 10.21 mL (139.94 mmol) in 50 mL of cooled MeOH.  The reaction 
was allowed to stir overnight at room temperature under Ar.  The reaction mixture was 
concentrated under vacuum and washed with MeOH.  6.44 g of crude L-tyrosine methyl 
ester (99% yield) was obtained after drying under vacuum overnight.  The crude product 
was further dissolved in 120 mL tetrahydrofuran (THF)/H2O (3:1).  Na2CO3 3.37 g (31.80 
mmol) was then added, and the reaction was stirred for 10 min.  Then 6.98 g Boc2O was 
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added, and the solution was stirred at room temperature overnight.  100 mL H2O was added 
to the solution and then the reaction was acidified with 3 M HCl to pH 3.  The organic layer 
was extracted with ethyl acetate (EtOAc), dried with MgSO4, and concentrated under 
reduced pressure.  The product can be recrystallized by dissolution in THF/hexane (3:1).  
N-Boc-L-tyrosine methyl ester (4.50 g, 15.24 mmol) was further dissolved in 30 mL 
CH2Cl2.  Triethylamine (6.38 mL, 45.72 mmol), 4-(dimethylamino) pyridine (0.186 g, 
1.524 mmol), and N-phenyl bis(trifluoro-methanesulfonimide) (7.62g, 21.34mmol) were 
then added, respectively.  The reaction was stirred overnight.  The reaction mixture was 
concentrated under reduced pressure and worked up with NH4Cl and then extracted by 
EtOAc.  The crude product was purified by flash chromatography, eluting with 8:2 
hexanes/EtOAc. (Rf = 0.26).  The purified product Boc-L-Tyr-OTf-OMe (3) was obtained 
as colorless oil 5.77 g (88.62% yield).  ESI-LRMS and NMR spectra matched previous 
reports.46 
 
(S)-Methyl 2-((4-(2-((tert-butoxycarbonyl)amino)-3-methoxy-3-oxopropyl)phenyl) 
amino) benzoate (5). 75 mL degassed toluene was added to Boc-L-Tyr-OTf-OMe (12) 
(3.000 g, 7.02 mmol) in a dried round-bottom flask, followed by methyl 2-aminobenzoate  
(4) (1200 µL, 9.27 mmol).  The solution was degassed with Ar for 5 min.  Then 
palladium(II) acetate (0.082 g, 0.365 mmol), and racemic 2,2ʹ- bis(diphenyl-phosphino)-
1,1ʹ-binaphthyl (0.054 g, 0.087 mmol) were added to the flask.  Cesium carbonate (6.88 g, 
21.1 mmol) was ground and added to the flask.  The flask was then fitted with a reflux 
condenser and heated to 135 °C for 23 h.  After the solution was allowed to cool to ambient 
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temperature, the contents were filtered through a short plug of silica gel using CH2Cl2 to 
transfer the material to the silica (200 mL), and then ethyl acetate (300 mL) was used to 
elute the product.  The clarified solution was then concentrated under reduced pressure and 
further purified by flash column chromatography (9:1 Hexane/EtOAc) afforded 2.759 g of 
compound 5 (6.44 mmol, 91.7%) as a yellow oil. (Rf = 0.2 in 85:15 Hexane/EtOAc)  ESI-
LRMS and NMR spectra matched previous reports.46 
 
Acridon-2-ylalanine (Acd, 1) (H2SO4 route). A solution of 13.5 M sulfuric acid (12 mL) 
was added to a flask containing 5 (1.02 g, 2.38 mmol).  The flask was then fitted with a 
reflux condenser and heated to 115 °C for 16 h in an oil bath.  80 mL water was then added 
to the flask and allowed to stir for 15 min.  The reaction was then removed from the hot oil 
bath and allowed to cool down.  Upon reaching ambient temperature, the solution was 
cooled to 4 °C and allowed to stand for 2 h.  100 g of ion-exchange resin (DowexÒ 50WX8 
hydrogen form, strongly acidic cation exchange resin) was made into a slurry with 1.8 M 
aqueous H2SO4 and applied to a flash chromatography column.  The resin was washed with 
350 mL 1.8 M aqueous H2SO4, 2 L of water, 1 L of 1.5 M aqueous NH4OH, and 4 L of 
water.  Following these washes, the resin was dried by passing air through the column.  The 
cooled Acd solution was then vacuum filtered on a Büchner funnel to remove precipitated 
material, and the clarified solution was applied to the washed and dried ion-exchange resin.  
The resulting resin slurry was shaken in the chromatography column for 5 min before the 
solution was drained.  This solution was then reapplied to the dried resin and shaken for an 
additional 5 min.  The twice-passed solution was then set aside.  The loaded resin was 
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washed with 4 L water before the compound of interest was eluted with 1.45 L of 1.5 M 
NH4OH.  The solution was concentrated to 50 mL by rotary evaporation, and then 
lyophilized to dryness, yielding a crop of Acd (1) as a yellow powder (0.6375 g 2.26 mmol 
94.9%).  The ion-exchange resin was recycled by washing with 4 L of water and dried until 
further use.  To maximize yield, the twice-passed solution was reapplied to washed and 
dried ion- exchange resin, and the process was repeated to yield a second crop of Acd 
(0.0232 g of 0.082 mmol 3.4%). 
 
Acridon-2-ylalanine (Acd, 1) (PPA route). Compound 5 2.16 g (5.04 mmol) was added 
to a round-bottom flask.  Then 50 mL THF was added and the solution cooled to 4 °C.  
LiOH (3.31 g, 138.15 mmol) was dissolved with 150 mL water.  The LiOH solution was 
then slowly added to the reaction.  The mixture was stirred under Ar at 4 °C overnight.  
The pH of the reaction mixture was adjusted to 3 with 6 M HCl.  Crude product was 
extracted with CH2Cl2 (3 x 100 mL), dried with MgSO4, and concentrated under reduced 
pressure.  The resulting crude oil was re-dissolved in 25 mL CH2Cl2 and cooled to 4 °C for 
16 h.  A first crop of recrystallized product was collected by vacuum filtration and washed 
with 100 mL of cold CH2Cl2 (1.63 g, 4.08 mmol, 80.8 %).  The product was obtained as a 
white powder (82.6 % yield).  The product was further reacted with polyphosphoric acid 
(PPA). 
66.62 g of polyphosphoric acid (PPA) was added into a round-bottom flask with a 
stir bar. A round-bottom flask was heated to 135 °C in an oil bath.  The (S)-2-((4-(2-((tert-
butoxycarbonyl)amino)-2-carboxyethyl)phenyl)amino)benzoic acid (1.43 g, 3.57 mmol) 
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was added to the flask and stirred for 2 h.  Then 50 mL water was slowly added (2 mL 
portions over 10 min) and the reaction allowed to cool to 60 °C.  After stirring for 1 h at 
60 °C, the reaction was cooled to ambient temperature.  Insoluble impurities were removed 
by vacuum filtration and the clarified solution was adjusted the pH to 4 by addition of 8 M 
NaOH.  Then the solution was cooled to 4 °C for precipitation about 16 h.  Crude product 
was collected by vacuum filtration.  After drying, the crude material was re-suspended in 
50 mL water and brought into solution by adjusting the pH to 9.0.  Insoluble impurities 
were removed by vacuum filtration.  The pH of the clarified solution was then adjusted to 
5.5 with 6 M HCl.  The yellow precipitate was collected by vacuum filtration and dried 
overnight affording 0.66 g of Acd (1) (1.86 mmol, 65.3% yield). 
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Figure 2.6 Fluorescence measurements of RSs with GFP reporter.  Grey, green, and blue represent 
fluorescence from colonies induced in media containing no Uaa, 1 mM Acd, or 1 mM Npf, 
respectively.  Expressions of 500 µL were grown for 48 hours before 2-fold dilution of suspended 
cells directly from culture with PBS.  Fluorescence measurements were collected using a 
BIOTEK® Synergy 2 Microplate Reader. 
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Table 2.2 Sequence of top performing AcdRSs.  The A9 and G11 clones were moved into the 
pDule2 plasmid for protein expression. 
Variant 
Residue number 
32 65 70 108 109 155 158 159 162 
WT Y L H F Q Q D I L 
G2 G E H W M Q S I K 
A9 A D H L E Q S I T 
B11 G V H L L Q E I T 
E2 G V H A S Q S I E 
H12 A W H T E Q G I A 
G11 A Y H H E Q S I S 
E6 G P H E S Q G I H 
E7 G P H E S Q G I H 
E10 G I H E S Q G I T 
G8 A P H S Q Q D I A 
G10 A W H R E Q G I S 
 
 
In Vivo Characterization of AcdRSs Selectivity 
Acd Mutant Calmodulin Protein Expression. For calmodulin (CaM) mutant expression, 
pCaM-L113TAG and pDule2-AcdRS plasmids was used to transform E. coli BL21(DE3) 
cells.46  The pDule2-AcdRS1, pDule2-AcdRS2a, and pDule2-AcdRS2b plasmids encode 
AcdRS1(G2), AcdRS2a(G11) and AcdRS2b(A9), respectively.  The pCaM-L113TAG 
plasmid confers ampicillin (Amp) resistance and the pDule2-AcdRS plasmids confer 
streptomycin (Strep) and spectinomycin (Spec) resistance.  Transformed cells were 
selected on the basis of Amp and Strep or Amp and Spec resistance.  Single colonies were 
used to inoculate 5 mL of LB media supplemented with Amp and Strep (100 µg/mL each).  
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To an autoclaved solution containing 42 mM Na2HPO4, 22 mM KH2PO4, 19 mM NH4Cl, 
and 86 mM NaCl (M9 salts), the following autoclaved solutions were added per liter of M9 
salts: 1 mL of 2 M MgSO4, 1 mL of 15 mg/mL FeCl2 (in 1.0 M HCl), 1 mL of 15 mg/mL 
ZnCl2 (in acidified H2O), 6.25 mL of 40% glucose, 100 µL of 1 M CaCl2 and 2 mL of 10% 
BactoTM Yeast Extract.  The primary 5 mL culture was incubated at 37 °C with shaking 
at 250 rpm for 4 h.  Upon reaching saturation, the primary culture was added to 1 L of M9 
minimal media supplemented with Amp and Strep (or Spec).  The 100 mL culture was 
incubated at 37 °C with shaking at 250 rpm until the OD600 reached 0.7.  At this point, the 
different amounts of unnatural amino acid were added to the culture depending on the 
following conditions: 
A: a solution of 28.23 mg Acd (1) from H2SO4 route in 5 mL sterile water 
B: a solution of 28.23 mg Acd (1) from PPA route 
C: a solution of 25.63 mg Npf (6) 
D: a solution of 0.26 mg Npf (6) and 27.95 mg Acd (1) 
E: a solution of 2.56 mg Npf (6) and 25.41 mg Acd (1) 
 
Acd was solubilized with 5 drops 10 M NaOH.  The protein expression was then 
induced with IPTG.  The culture was incubated at 37 °C for an additional 16 h.  The cells 
were harvested at 5000 x g for 15 min, and the resulting pellet was suspended in 15 mL of 
3-(N-morpholino) propanesulfonic acid (MOPS) resuspension buffer (50 mM MOPS, 100 
mM KCl, 1 mM EDTA, pH 7.5).  Following sonication, the cell lysate was allowed to cool 
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on ice for 5 min.  CaCl2 was added to the sonicated lysate to a final concentration of 5 mM 
prior to centrifugation for 20 min at 30,000 x g, 4 °C. 
CaM was purified from the cleared cell lysate using a phenyl-sepharose (PhS) CL-
4B column with EDTA as eluent.  Using a total resin bed volume of 10 mL, the column 
was first equilibrated with 4 column volumes of PhS Buffer A (50 mM Tris base, 1 mM 
CaCl2, pH 7.5).  After the cleared cell lysate was loaded and allowed to pass through the 
resin, the column was washed with 4 column volumes of PhS Buffer A, 4 column volumes 
of high-salt PhS Buffer B (50 mM Tris base, 0.5 M NaCl, 0.1 mM CaCl2, pH 7.5), and an 
additional 2 column volume washes of PhS Buffer A to restore low-salt conditions.  CaM 
was eluted with PhS Buffer C (10 mM Tris base, 10 mM EDTA, pH 7.5) and collected in 
1 mL fractions. The presence of protein was detected by SDS-PAGE.  Fractions containing 
protein were combined and dialyzed against water for 16 h at 4 °C. 
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Figure 2.7   In vivo AcdRS selectivity.  CaM (UAG codon at 113) was expressed in minimal media 
containing 1 mM Uaa: Acd, synthesized either using the H2SO4 route or PPA route, Npf, or either 
a 99:1 or 90:1 mixture of PPA Acd and Npf.  Expression was performed with either AcdRS1 (G2) 
or AcdRS2b (A9).  AcdRS2b (A9) can tolerate at least 10% Npf in the growth media with no 
apparent Npf incorporation. 
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Acd Mutant a-Synuclein Protein Expression.  
For α-synuclein (αS) mutant expression, E. coli BL21-Gold (DE3) cells were 
transformed with the αS-F94TAG plasmid and a pDule2 plasmid containing the AcdRS and 
tRNACUA pair.  Cells were selected for resistance to both Amp (100 µg/mL) and Strep (100 
µg/mL) or Spec (50 µg/mL).  Single colonies were used to inoculate 4 mL of LB media.  
The primary culture was grown at 37 °C with shaking at 250 rpm for 4 h.  The 100 mL 
culture was incubated at 37 °C with shaking at 250 rpm until the OD600 reached 0.8 AU.  
At this point, the different amounts of unnatural amino acid were added to the culture 
grown under conditions A-E as in the CaM protocol above.  The cells were harvested at 
5000 x g for 15 min and the resulting pellet was resuspended in 20 mM Tris, pH 8.0 with 
1 mM PMSF and sonicated.  Following sonication, the cell lysate was boiled for 15 min 
prior to centrifugation for 20 min at 13,200 x g, 4 °C.  The cleared lysate was dialyzed 
overnight against 20 mM Tris, pH 8.0 at 4 °C prior to purified using a HiTrap Q HP column 
(GE Healthcare).  FPLC fractions were dialyzed against 20 mM Tris, pH 8.0 and stored at 
4 °C. 
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Figure 2.8 In vivo AcdRS selectivity.  αS (UAG codon at 94) was expressed in LB media 
containing 1 mM Uaa: Acd, synthesized either using the H2SO4 route or PPA route, Npf, or either 
a 99:1 or 90:1 mixture of PPA Acd and Npf.  Expression was performed with either AcdRS1 (G2) 
or AcdRS2b (A9).  AcdRS2b (A9) can tolerate at least 10% Npf in the growth media with no 
apparent Npf incorporation.  * indicates MALDI matrix adduct.  αSNpf94, Calc’d: 14482; αSAcd94, 
Calc’d: 14508. 
 
Trypsin Digest Analysis of Acd Mutants.  
Protein Acd mutants were precipitated using 1:4 8.75 M trichloroacetic acid/protein 
sample and incubated at 4 °C for 15 minutes.  The precipitate was centrifuged for 15 min 
at 13,200 rpm to pellet protein.  The protein pellet was then washed three times with cold 
acetone to remove trace trichloroacetic acid.  Trace acetone was removed by incubating 
protein pellets in a 95 °C water bath for 5 min open to the atmosphere.  Protein pellets were 
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then re-suspended in 6 M guanidinium hydrochloride with 50 mM Tris pH 8.0, and 
denatured by boiling at 95 °C for 10 minutes.  Protein samples were then diluted to 0.75 M 
guanidinium hydrochloride with 50 mM Tris pH 7.6 and 1 mM calcium chloride.  
Sequencing grade modified trypsin (0.6 µg, Promega) was used to digest samples for 24 
hours at 37 °C.  Trypsin digest aliquots (1 µL) were combined with α-cyano-4- 
hydroxycinnamic acid (1 µL of a saturated solution in 1:1 H2O/CH3CN with 1 % TFA) and 
analyzed by MALDI-MS. 
 
Table 2.3 CaM 113 trypsin digest intensity scaling. 
 
Uaas 
G2 A9 
m/z Peak Height Scaled Peak m/z Peak Height Scaled Peak 
Acd (H2SO4) 
1153.8 391 2277 1153.7 13 57.6 
1179.8 8166 1458 1179.7 5878 1083.1 
1349.9 5661  1349.8 1348  
Acd (PPA) 
1153.7 24  1153.7 38  
1179.8 7574  1179.7 15487  
1349.9 1091  1349.8 4132  
Npf 
1153.8 518  1153.7 90  
1179.8 15  1179.5 10  
1349.9 3500  1349.8 493  
1% Npf/Acd 
1153.8 1224 7281 1153.4 17 73 
1179.8 20839 3801 1179.7 5386 984 
1349.9 7968  1349.8 1922  
10% 
Npf/Acd 
1153.8 3034 18197 1153.5 22 121 
1179.8 754 15 1179.7 1621 294 
1350.0 10266  1349.8 790  
 
CaM108-116Acd113/ CaM117-127 Scaling Factor: 5.47 
CaM108-116Npf113/ CaM117-127 Scaling Factor: 0.165 
 
CaM108-116Npf113/ CaM117-127 Background Factor: 0.0156 
CaM108-116Acd113/ CaM117-127 Background Factor: 0.0122 
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LexA Cloning/Expression/Purification.  
(Note: LexA proteins were expressed and purified by Zachary M. Hostetler. Trypsin 
digestions and MALDI-MS characterization were performed by Itthipol Sungwienwong ) 
To create a C-terminal His-tagged LexA expression construct, a recombinant E. coli 
lexA gene containing the S119A catalytically-inactive mutation was PCR amplified with 
forward75 
A: 5’-GGCAGCCATATGAAAGCGTTAACGG-3’ 
and reverse 
B: 5’-AATCTCGAGCCAGTCGCCGTTGC-3’ 
primers.  This amplified lexA gene was sub-cloned into the NdeI and XhoI sites in pET-
41a(+) plasmid (EMD Millipore) to produce pET41-LexA-S119A-HIS.  To generate an 
amber stop codon in the S60 position, the pET41-LexA-S119A-HIS plasmid was amplified 
with forward 
C: 5’-ATTGTTTAGGGCGCATCACGCGGAATTCGTC-3’ 
and reverse 
D: 5’-GTGATGCGCCCTAAACAATTTCAATAACGCC-3’ 
primers designed for site-directed mutagenesis with Phusion polymerase, creating pET41-
LexA-S60TAG-S119A-HIS.76 
Chemically competent BLR(DE3) cells (EMD Millipore) were transformed with 
either of the above pET41-LexA plasmids (Kn resistance) and either of the pDule2-
AcdRS1a or pDule2-AcdRS2b plasmids (streptomycin resistance) and selected on LB + 
Kn (30 µg/mL) + Strep (100 µg/mL) plates.  Isolated colonies were grown overnight to 
saturation in liquid LB + Kn + Strep.  Overnight cultures were inoculated at a 1:100 ratio 
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into 25 mL MD-5051 auto-inducing medium containing 150 µg/mL Kn, 100 µg/mL Strep, 
and 1 mM acridone (H2SO4 route).77  Cultures were grown for 24 hours in sterile 250 mL 
polypropylene centrifuge tubes (Corning) in a shaking 37 °C incubator.  Cells were 
harvested at 4000 x g for 30 min at 4 °C. 
Cell pellets were resuspended in 4 mL of wash buffer (50 mM sodium phosphate, 
300 mM NaCl, 10 mM imidazole, pH 7.1) containing 1x BugBuster Protein Extraction 
Reagent (EMD Millipore), 0.5 mg/mL lysozyme, 25 U/µL benzonase, and 1x cOmplete 
EDTA-free protease inhibitor cocktail (Roche).  After incubation at room temperature for 
30 min, lysed cells were centrifuged at 20000 x g for 30 min at 4 °C.  LexA proteins were 
purified from the clarified cell lysate using 0.5 mL HisPur cobalt spin columns per 
manufacturer’s instructions (Thermo Scientific), using 300 mM imidazole as eluent.  LexA 
proteins were detected by running purification samples on 15% SDS-PAGE gels.  Elutions 
containing LexA were pooled and buffer-exchanged into low salt buffer (20 mM Tris-HCl, 
25 mM NaCl, pH 7.6) using Vivaspin 500 concentration devices. 
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Figure 2.9 In vivo AcdRS selectivity.  LexA (UAG codon at 60) was expressed in auto-induction 
media containing 1 mM Acd, synthesized using the H2SO4 route.  Expression was performed with 
either AcdRS1 (G2) or AcdRS2b (A9).  Although the whole protein peaks (left) are very broad, 
trypsin digest producing the LexA53-64 fragment (right) indicates the presence of only Npf in the G2 
sample and only Acd in the A9 sample.  * indicates MALDI matrix adduct.  LexA53-64Npf60, Calc’d: 
1366.5, Obsv’d: 1366.6; LexA53-64Acd60, Calc’d: 1392.5, Obsv’d: 1392.4 
 
 
AcdRS Cloning/Expression/Purification.  
(Note: These experiments were done together with Zachary M. Hostetler) 
Synthetic genes (IDT) for AcdRS1 and AcdRS2b were amplified with forward 
E: 5’-GAGCGGATAACAATTCCCCTCTAG-3’ 
and reverse 
F: 5’-GTGGTGGTGCTCGAGTCTCTTTC-3’ 
primers.  The resulting PCR product was digested with NdeI and XhoI and sub-cloned into 
a pBAD24 plasmid modified with a C-terminal His tag, resulting in the three pBAD24-
AcdRS-HIS constructs.  Chemically competent BL21(DE3) cells were transformed with 
one of the three above pBAD24-AcdRS-HIS plasmids (Amp resistance) and selected on 
  
 
61 
LB + Amp (100 µg/mL) plates.  Isolated colonies were inoculated into 200 mL arabinose 
auto-inducing medium containing 100 µg/mL carbenicillin (Carb).78  Cultures were grown 
for 24 hours in 2 L flasks in a shaking 37° incubator.  Cells were harvested at 4000g for 15 
min at 4°. 
Cell pellets were resuspended in 30 mL of wash buffer (50 mM HEPES-KOH, 500 
mM NaCl, 10 mM imidazole, pH 7.9) containing 1 mM PMSF and 1x cOmplete EDTA-
free protease inhibitor cocktail (Roche).  Cell suspensions were lysed using a French 
pressure cell (FA-032, Thermo Electron Corp) and then centrifuged at 20000g for 30 min 
at 4 °C (Sorvall RC 6+).  Clarified lysates were loaded with a BioLogic LP System (Bio-
Rad) onto a column containing 4 mL of packed HisPur resin (Thermo Scientific), and 
proteins were eluted with a linear imidazole gradient.  AcdRS proteins were detected by 
running elution fractions on 12% SDS-PAGE gels.  Elutions containing AcdRS were 
pooled and dialyzed three times against 2 L of 20 mM Tris-HCl pH 8.5, 50 mM NaCl, 10 
mM 2-mercaptoethanol, and 20% glycerol.  Dialyzed samples were loaded onto a 5 mL 
HiTrap Heparin HP column (GE Healthcare) and proteins were separated with a linear 
NaCl gradient.  FPLC fractions were analyzed by 12% SDS-PAGE, and those containing 
AcdRS proteins were concentrated using Amicon Ultra centrifugal filter units (Sigma), 
buffer-exchanged (50 mM HEPES-KOH pH 7.5, 20 mM NaCl, 10 mM MgCl2, 1 mM DTT, 
and 50% glycerol), and stored at -80 °C. 
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AcdRS Activity Test.  
The activity of each AcdRS enzyme was verified by monitoring pyrophosphate 
release during the initial condensation reaction of Acd or Npf with ATP.  To measure 
pyrophosphate, an enzyme-coupled, colorimetric assay recently described in the literature 
was used.79  Briefly, pyrophosphate generated during each reaction is hydrolyzed by excess 
inorganic pyrophosphatase (PPiase), and free orthophosphate is incubated with malachite 
green under acidic conditions (Malachite Green Phosphate Assay Kit, Sigma) to generate 
a malachite green phosphomolybdate complex (600-660 nm absorbance).  Several 
concentrations of each AcdRS enzyme (0, 0.5, 1.0, and 2.0 µM) were incubated in reaction 
buffer (50 mM HEPES-KOH pH 7.5, 20 mM NaCl, 10 mM MgCl2, 1 mM DTT) with 2 
U/ml PPiase (NEB), 1 mM of either Acd or Npf, and with or without 0.2 mM ATP for 35 
min at 37 °C.  Reactions were quenched with chilled EDTA to a final concentration of 10 
mM.  Samples were developed per manufacturer’s instructions in a clear 96-well plate 
(Corning Costar), and absorbances at 620 nm were read in an Infinite F200 plate reader 
(Tecan).  Standard curves were used to interpolate observed phosphate concentrations, and 
the data describing calculated pyrophosphate release rate versus AcdRS concentration were 
fit to a straight line. 
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Figure 2.10 AcdRS purification. Left: SDS-PAGE gel showing purification samples of AcdRS1 
(G2, lanes 2-7) and AcdRS2b (A9, lanes 8-13) taken throughout the cell lysis and HisPur affinity 
resin steps.  Right: SDS-PAGE gel showing final, purified samples of both AcdRS enzymes 
following the purification scheme described in the supplemental text.  For the lanes in each gel, an 
equal volume of sample and Laemmli buffer (Bio-Rad) were mixed, boiled at 95°, centrifuged, and 
loaded onto 12% SDS-PAGE gels, which were run for 50 min at 200 V. 
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Figure 2.11 AcdRS malachite green activity assay.  Plots showing rate of inorganic pyrophosphate 
formation versus AcdRS concentration for AcdRS1 (G2, left) and AcdRS2b (A9, right).  Data are 
from reactions at 37° containing either 1 mM Acd (blue) or 1 mM Npf (green) and in the presence 
(solid points) or absence (open points) of 0.2 mM ATP.  The linear dependence of activity on 
AcdRS concentration was demonstrated by fitting a straight line through the data points. 
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Figure 2.12 Representative primary data for aminoacylation.  Left: TLC plate showing reactions 
of the AcdRS2b(A9) enzyme with saturating levels of orthog-tRNA and Acd at varying times.  
There is almost complete aminoacylation by the end of the timecourse (about 5 min).  Right: 
Timecourse for the AcdRS2b(A9) reaction fit to derive kobs. 
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CHAPTER 3: The Design of Fluorescent Unnatural Amino Acids Based on the 
Acridone Scaffold 
 
 
Adapted in part with permission from Sungwienwong, I.; Ferrie, J. J.; Jun, J. V.; Liu, 
Chunxiao; Barrett, T. M.; Hostetler, Z. M.; Ieda, Naoya; Hendricks, Amara; Muthusamy, A. K.; 
Kohli, R. M.; Chenoweth, D. M.; Petersson, G. A.; Petersson, E. J., Improving the Fluorescent 
Probe Acridonylalanine Through a Combination of Theory and Experiment. J. Phys. Org 
Chem. 2018; e3813. Copyright (2018) John Wiley & Sons, Ltd. 
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Introduction 
 Fluorescence spectroscopy can be a valuable tool for studying the structural 
dynamics of proteins and protein/protein interactions.54 There are several common types 
of protein experiments that employ fluorescence spectroscopy: folding/conformational 
change experiments, binding experiments, and proteolysis experiments80-81 (Figure 3.1). 
Changes in fluorescence can be used to track protein structural change on the ns timescale 
using distance dependent chromophore interactions: either Förster resonance energy 
transfer (FRET) or quenching by photo-induced electron transfer (eT).81-83 Such studies 
require fluorescent probes that enable accurate measurement on a variety of distance ranges 
between the two chromophores.  FRET ranges are characterized by the Förster radius, R0, 
the distance of half-maximal energy transfer for any chromophore pair.84 For example, the 
common FRET pair fluorescein (Fam)/ tetramethylrhodamine (Tmr) has an R0 of 47 Å and 
is useful to measure distances in the 30 to 90 Å range.85  Since many inter-residue distances 
in proteins are shorter than this, one needs to complement the Fam/Tmr FRET pair with 
other probe pairs that are better suited to shorter interactions.  With this in mind, the 
Petersson laboratory has developed a methoxycoumarinylalanine (Mcm, 1)/ 
acridonylalanine (Acd, 2) FRET pair for monitoring distances in the 15 to 40 Å range, and 
thioamide/Mcm or thioamide/Acd eT quenching pairs for short distance (<15 Å) 
measurements.86-87 
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Figure 3.1 FRET experiments. Left: Protein conformational changes, protein–protein interactions, and 
proteolytic cleavage can be monitored by changes in the intra- or intermolecular distance between two FRET 
(Förster resonance energy transfer) probes. 
 
 In addition to being better suited to short distance ranges than Fam or Tmr, Acd is 
small enough to be directly genetically incorporated, rather than post-translationally 
attached, and is less likely to disrupt protein folding.8  This allows one to place a 
chromophore on the interior of a protein and to label proteins that cannot be reversibly 
unfolded and refolded (e.g., our published labeling of LexA).88 Having the chromophore 
attached by a short sidechain rather than a Cys maleimide or “click” chemistry triazole 
linker also reduces the positional uncertainty of the FRET probe with respect to the protein 
backbone.  Thus, distance measurements from FRET should more reliably report on 
changes in protein conformation.  We and others have previously shown that Acd can be a 
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valuable probe for protein study because of its small size (222 Å3), high quantum yield in 
water (F = 0.95), unusually long fluorescence lifetime (t ~15 ns), and high 
photostability.45-46, 57 We have developed an engineered aminoacyl tRNA synthetase (RS)/ 
orthogonal tRNA pair for selective Acd incorporation by unnatural mutagenesis.46  This 
has allowed us to label proteins and peptides with methoxycoumarin/Acd FRET pairs 
either through Mcm incorporation by solid phase peptide synthesis (SPPS) or by 
attachment of methoxycoumarin-maleimide to a Cys residue in a protein.86 While many 
aspects of the Mcm/Acd FRET pair are optimal, such as significant spectral overlap and a 
high Mcm extinction coefficient at 325 nm where Acd has a minimum, one disadvantage 
is the small Acd Stokes shift which leads to significant overlap of their emission spectra.  
This overlap necessitates a challenging deconvolution of the Mcm/Acd spectra in order to 
determine FRET efficiencies and distance measurements.  Thus, an Acd derivative with a 
larger Stokes shift would be desirable for Mcm FRET. 
 In addition to improving Mcm FRET, we also wish to alter other fluorescent 
properties of Acd, such as red-shifting excitation and emission, increasing the extinction 
coefficient, and altering solvatochromic effects to make brighter derivatives that are better 
suited to microscopy or single-molecule fluorescence applications.  Sisido and coworkers58 
have previously shown that some of these effects can be achieved by simply homoligating 
Acd with a benzene ring (benzoacridonylalanine or Bad, 3) to extend the π-system. 
However, we wish to make derivatives that can still be incorporated by the ribosome, and 
Sisido’s laboratory also showed that Bad was not incorporable during in vitro translation 
with chemically-charged tRNA.  Therefore, we will use crystal structures and 
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computational models of our evolved AcdRS and “rules” for ribosomal permissivity 
established in previous in vitro translation studies46, 89 to restrict Acd substitutions to 
positions that will allow in vivo tRNA charging and incorporation into proteins. 
 
 
 
 
 
 
 
Figure 3.2 Fluorescent amino acids based on 7-methoxycoumarin and acridone cores. 
 
Identifying Acd derivatives by making amino acid analogs is synthetically 
laborious and unnecessary given that Acd and Bad spectroscopic properties are identical 
to the properties of the respective chromophore cores.45, 57-58  Thus, to improve Acd 
fluorescence, we set out to make a series of acridone (5) core derivatives in order to identify 
derivatives with sufficiently improved properties to warrant synthesis of the amino acid 
form for incorporation into peptides.  Previous studies of acridone derivatives have shown 
that many of the spectroscopic properties can easily be modulated through substituent 
effects, providing strong precedent for our work.13, 58, 90-96 Moreover, focusing on the 
acridone core makes computational modeling more tractable, with the potential to further 
narrow the scope of synthetic work by predicting absorption and emission spectra. 
 Here, we prepare a series of acridone derivatives in order to validate the accuracy 
of our electronic structure calculations and identify a derivative, aminoacridonylalanine 
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(Aad, 4) with substantially red-shifted emission.  In addition, our calculations help to 
explain the origin of fine structure in acridone spectra, an explanation which is in conflict 
with the conclusions of previous computational and experimental Acd spectroscopy 
studies, but is consistent with the larger body of acridone literature.  Finally, we synthesize 
Aad and perform initial trials toward its genetic incorporation. 
 
Results and Discussion:  
Acridone derivative syntheses 
To synthesize acridone cores that were not commercially available, we used two 
general strategies, functionalization of acridone and cross-coupling of pre-functionalized 
aryl units.  Nitration of acridin-9(10H)-one 5 was performed with HNO3 in CH3COOH at 
50 oC, giving a mixture 2-nitroacridin-9(10H)-one (6) and 4-nitroacridin-9(10H)-one (7) 
(variations in reaction conditions produced a 74% yield of 6 or 38% yield of 7, see 
Experimental Methods section for details). Reduction of 6 and 7 using Na2S and NaOH in 
refluxing EtOH/water gave 2-aminoacridin-9(10H)-one (8) and 2-aminoacridin-9(10H)-
one (9), respectively, in quantitative yields (Na2S used for small scale, Pd/C also used to 
reduce 7, see experimental details section for details).97 (Scheme 3.1) 
 
Scheme 3.1 Synthesis of nitroacridones (6 and 7) and aminoacridones (8 and 9). 
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We also used Buchwald-Hartwig cross-coupling amination between methyl 2-
aminobenzoate (10) and aryl bromides 11-12, followed by Friedel-Crafts cyclization, to 
generate several acridone derivatives.98  Cross-coupling was accomplished using 
Pd(OAc)2, racemic 2,2′-bis(diphenyl-phosphino)-1,1′-binaphthyl (rac-BINAP), and 
Cs2CO3 to generate methyl 2-(phenylamino)benzoates 13 and 14 in 86 and 78% yield, 
respectively.  Then the acridone cores were achieved by saponification with LiOH, 
followed by Friedel−Crafts cyclization, to give 4-fluoroacridin-9(10H)-one (15, 93%) and 
4-methoxyacridin-9(10H)-one (16, 96%). (Scheme 3.2) 
 
 
 
 
 
 
 
 
Scheme 3.2 Synthesis of acridones 15 and 16 and benzoacridones 18-20. 
 
The same strategy was used to form benzoacridone derivatives.  Buchwald-Hartwig 
cross-coupling with methyl 3-amino-2-naphthoate (17) and aryl bromides (11-12 and 
bromobenzene) gave the corresponding methyl 3-(phenylamino)-2-naphthoates in 97-98% 
yields (see experimental details section).  Then the benzo[b]acridin-12(5H)-one derivatives 
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(18-20) were formed by hydrolysis and Friedel−Crafts ring-closing reactions in 85-89% 
yields. (Scheme 3.2) 
 These methods provided access to many acridone derivatives for this study and are 
sufficiently general to provide access to most desired derivatives for future studies.  In 
particular, the cross-coupling route allows us to access derivatives, such as 3-
aminoacridone, that may be difficult to synthesize using nucleophilic aromatic substitution, 
as the directing effects of the ortho carbonyl and amino groups on each benzene ring in the 
acridone core would strongly favor reactions at the 2- or 4- positions. 
 
Spectroscopic characterization 
 Following production of the various Acd derivatives, we determined the 
absorbance and emission profiles, as well as the extinction coefficient, of each core.  These 
data are summarized in Figure 3.3 and Table 3.1, and the spectra of each compound are 
reported separately in the experimental method section.  The absorption and emission 
spectra are normalized in Figure 3.3 for clarity, raw spectra are shown in the experimental 
method section and extinction coefficients and emission intensities are given in Table 3.1.  
Since we ultimately endeavor to utilize these derivatives as fluorescent unnatural amino 
acids, we attempted to perform the spectroscopic characterization in phosphate-buffered 
saline (PBS), pH 7.4.  However, due to the relatively low solubility of the benzoacridone 
compounds in water, all measurements were performed in 1:1 acetonitrile/PBS.  Extinction 
coefficients were obtained through serial dilutions of stocks of 300 µM, which is 
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approximately the solubility limit of benzoacridone in acetonitrile.  Fluorescence emission 
spectra were acquired under the same solvent conditions. 
 The parent acridone (5) absorbance spectrum features two major peaks in the near 
UV region with maxima at 382 and 398 nm as well as additional features below 300 nm.  
Derivatization of the acridone core resulted in changes of the absorbance profile that were 
both functional group and position dependent.  For example, introducing a methoxy group 
in the 2 position in S1 resulted in a ~15 nm red-shift in the absorbance maximum, with 
minimal modulation of the line shape, while introduction at the 4 position in 16 resulted in 
a very minimal shift, with the multi-peak profile becoming less defined.  Amino 
modification at either the 2 or 4 position produces a singular broad feature that is 
significantly red-shifted.  Moreover, the absorbance profile of 2-aminoacridone (8) is pH 
sensitive (see Figure 3.11).  The spectrum takes on a single broad absorbance feature very 
similar to that of 4-aminoacridone (9) at high pH, which is dramatically reduced at low pH.  
It is important to note that both the unmodified and the 4-amino Acd chromophores are pH 
insensitive (see Figure 3.10 and 3.12).  Lastly, we observe that extension of the conjugated 
system in the case of benzoacridone (18) results in an expected shift of the absorbance to 
higher wavelengths, but displays an unexpected reduction in the extinction coefficient.  
When modified with either fluoro (19) or O-methyl (20) substituents, the absorbance 
profile is minimally shifted and the peaks become less well-resolved, similar to what was 
observed when modifying the parent acridone scaffold (15 and 16). 
Acridone substitution also elicited changes in the emission profile and Stokes shift.  
The unmodified acridone emission features two major peaks at 412 and 435 nm with a 
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minor peak around 460 nm.  As in the absorbance profiles, the maxima of these peaks move 
to lower energy upon modification with the O-methyl group (S1 or 16) with the multi-peak 
profile becoming less defined.  Similarly, introduction of the amine functionality resulted 
in a significant red shift as well as a reduction of the multi-peak line shape to a single broad 
emission.  Both compounds 8 and 9 exhibited a dramatic increase in Stokes shift of ~100 
nm compared to the acridone core.  Both also displayed a sensitivity to pH, manifested as 
a decrease in emission intensity with decreasing pH, compared to the unmodified core 
whose emission is insensitive to pH changes in the 2-10 range.  Finally, the benzo modified 
acridone analogs all feature a nearly identical emission profile ~100 nm red shifted from 
the emission of the parent acridone compound.  The combination of benzo and fluoro or 
methoxy substitution further red-shifts the absorption spectrum, but does not appreciably 
change the emission spectrum. 
 
 
 
  
 
76 
 
Figure 3.3 Absorption and emission spectra of acridone derivatives.  Spectra determined in 1:1 
acetonitrile/PBS, pH 7.4.  Spectra are shown normalized to enable comparison of changes in 
absorption and emission maxima.   
 
Electronic structure calculations 
(Note: Calculations were performed by Professor George A. Petersson) 
In order to understand the nature of the substituent effects on acridone fluorescence, 
we performed ab initio electronic structure calculations of the absorption and emission 
spectra for all of the core derivatives.  The calculations employed the APF-D density 
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functional as implemented in the Gaussian16™ suite of programs with the 6-311+G(2d,p) 
basis set which has been recommended for calculations of fluorescence spectra.99-101  The 
close agreement between the calculated (Calc.) and experimental (Obs.) spectra for the 
parent species, acridone, clearly justifies this choice. (Figure 3.4) For microscopy and 
spectroscopy applications, the useful transition is not the expected intense C=O n ® π* 
excitation at 253/255 nm (Calc./Obs.).  Rather, it is the weaker π ® π* excitation with 
peaks at 366/376 nm (Calc./Obs.) and 384/402 nm (Calc./Obs.).  The emission spectrum 
shows a ~10 nm Stokes shift with π* ® π emission peaks at 396/412 nm (Calc./Obs.) and 
418/436 nm (Calc./Obs.).  We note that although the agreement of the calculated and 
observed extinction coefficients is excellent for the n ® π* transition, the calculations 
overestimate the intensity of the π ® π* absorption.  However, what is most important is 
that throughout the series of acridone derivatives, the wavelengths and intensities of the     
π ® π* absorption and emission track very well with the experimental data, showing that 
the calculations can clearly predict acridone derivative properties to guide synthetic efforts. 
(Table 3.1) 
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Figure 3.4 Calculated acridone spectra.  Top Left: Experimental and calculated, Franck-Condon 
corrected spectra, with vertical transitions used to determine the calculated spectrum shown.  
Bottom Left: Primary molecular orbitals (MOs) involved in the n ® π* (~250 nm) and π ® π* 
(~380 nm) transitions of acridone.  Right: Jablonski diagram showing strategy for using frozen 
ground or excited state solvation in geometry optimization and frequency calculations to determine 
electronic spectra. 
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Table 3.1 Calculated and observed photophysical parameters of acridone derivatives.a 
  Calculated  Observed 
Compound  lex/eb lem/Int.c  lex/eb lem/Int.c 
Acd 5  383/2.43 00411/1.00  398/0.70 412/1.00 
2-NO2 6  408/1.87 -  402/0.37 - 
4-NO2 7  464/2.06 -  434/0.60 - 
2-NH2 8  419/0.47 508/0.21  420/0.52 527/0.16 
4-NH2 9  400/0.61 492/0.59  400/0.59 540/0.01 
4-F 15  365/1.19 397/0.48  378/0.51 412/0.65 
2-OMe S1  400/0.95 444/0.47  396/0.82 447/0.63 
4-OMe 16  375/0.62 421/0.35  384/0.69 431/0.37 
Bz 18  446/0.81 495/0.31  438/0.58 507/0.42 
4-F-Bz 19  446/0.61 496/0.24  448/0.54 508/0.21 
4-OMe-Bz 20  456/0.67 512/0.25  454/0.61 512/0.14 
aLowest energy absorption and highest intensity emission data reported here.  A full list of absorption and 
emission peaks are found in Table 3.3 in experimental method section. 
bExtinction coefficients (e) reported as 104 M-1cm-1. 
cEmission intensity (Int.) normalized the intensity of the highest emission peak of acridone for both calculated 
and observed spectra. 
 
 
 
For acridone, we performed more sophisticated calculations, combining Franck-
Condon integrals from vibrational calculations to generate spectra representing acridone 
absorption and emission spectra in aqueous solution.  Bonding in excited states is generally 
not as strong as in ground states, which reduces the zero-point-energy (ZPE) from 
molecular vibrations.  For example, the ZPE for the lowest-lying π ® π* excited state of 
acridone (115.76 kcal/mol) is 2.21 kcal/mol less than the ZPE for the ground state (117.97 
kcal/mol).  This reduces the vertical excitation energy to 78.20 kcal/mol (lex = 366 nm).  
The electronically excited state then relaxes through internal conversion to its vibrational 
ground state, lowering the energy by 3.85 kcal/mol.  This is followed by solvent relaxation 
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which lowers the energy of the excited state by an additional 1.19 kcal/mol, and raises the 
ground state energy by 0.94 kcal/mol (Figure 3.4).  The vertical emission (68.61 kcal/mol 
or lem = 418 nm) is followed by relaxation through internal conversion to the vibrational 
ground state, lowering the energy by 3.61 kcal/mol.  Solvent relaxation then lowers the 
energy of the ground state by an additional 0.94 kcal/mol.  We found that these Franck-
Condon corrected spectra have excellent agreement with the observed acridone spectra, 
particularly for the features in the π ® π* absorption and emission peaks.  We note that 
previous computational studies of acridone by Oshima, accompanied by gas phase 
electronic spectra measurements, concluded that the various vibronic modes that they 
observed for the π ® π* absorption and emission were the result of different hydration 
clusters.102-104 While this explanation may be valid for gas phase measurements, solution 
phase measurements show a similar spectral shape for acridone absorption and emission in 
polar, hydrogen-bonding solvents like water, and in non-polar solvents like THF.57  Thus, 
the explanation arising from our Franck-Condon corrected calculations (determined with 
continuum solvation), that the multiple peaks at ~380 nm arise from internal acridone 
vibrational modes, seems to fit better with solution phase data. 
 
 
Synthesis of aminoacridonylalanine for protein studies 
 
We chose to generate the amino acid form of 2-aminoacridone (8) since its emission 
was as red-shifted as any of the benzo derivatives, but its smaller size and greater polarity 
make it more favorable for eventual genetic incorporation.  While the absorption and 
  
 
81 
emission spectra of 2- and 4-aminoacridone are relatively similar, the 2-amino isomer was 
chosen because it is brighter and our modeling studies (below) suggest that it is likely to 
be genetically incorporable.  Since the 2-aminoacridone core shows a larger Stokes shift 
than the acridone core with comparable spectral overlap and selective excitability (i.e., the 
maximum in Mcm absorbance coincides with a minimum in Acd or Aad absorbance) it can 
function as a superior FRET partner for Mcm.  Our spectral overlap calculations indicate 
that acridonylalanine (Acd, 2) and aminoacridonylalanine (Aad, 4) have similar R0 values 
(Acd: 25.3 Å, Aad: 26.5 Å), but the emission of Aad at 530 nm will be easier to monitor in 
ratiometric FRET experiments and no deconvolutions with Mcm emission will be 
necessary (Figure 3.5).  Although 2-aminoacridone is commonly used in glycan 
experiments, and acyl 2-aminoacidone peptides have been used previously in protease 
sensors, to our knowledge, amino acid forms such as Aad have not been made previously 
or used in FRET applications.92, 105 
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Figure 3.5 Aad is a Superior FRET Acceptor for Mcm.  Top: Absorbance (solid lines) and 
fluorescence emission (dashed lines) of Mcm (purple), Acd (blue), and Aad (orange) with spectral 
overlap shaded.  Both Acd and Aad have low absorbance at the excitation maximum of Mcm (325 
nm) and comparable spectral overlap (shaded areas), but Aad emission can more easily be 
distinguished from Mcm emission.  Bottom Left: Normalized changes in FRET ratio (380/480 nm 
for Acd, 380/530 nm for Aad) of 5 µM Xxx-Leu-Leu-Lys-Ala-Ala-Ala-Mcm (Xxx = Acd or Aad) 
peptides upon rapid mixing with 1 µM trypsin protease.  Data points from three trials shown to 
demonstrate reproducibility, with average shown as a smooth curve.  Bottom Right: Fluorescence 
emission spectra, with excitation at 325 nm, of Acd or Aad peptides before and after proteolysis.  
Spectra normalized based on area under the curve. 
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Acd (2) was synthesized as we have previously reported.  Nitration of Acd was 
carried out similarly to nitration of acridone, affording a single nitro isomer in 39% isolated 
yield (>90% conversion based on integration of the chromatogram).  The nitration reaction 
mixture was basified and sodium sulfide added to perform the reduction to give Aad (4) in 
86% yield. (see experimental details section) The position of the amino group was 
confirmed by NMR and by comparison of the absorption and emission spectra to the 
spectra of 2- and 4-aminoacridone (8 and 9).  Protected forms of Acd and Aad were 
generated for solid phase peptide synthesis, and the peptides Xxx-Leu-Leu-Lys-Ala-Ala-
Ala-Mcm (Xxx = Acd or Aad) were synthesized.  The peptide sequence was chosen as a 
protease substrate based on previous studies in our laboratory so that cleavage should result 
in a decrease in FRET.106  Cleavage by the proteases trypsin and cathepsin B was tested by 
exciting at 325 nm and monitoring emission at 380 nm (Mcm) and either 480 nm (Acd) or 
530 nm (Aad).  After confirming that trypsin proteolysis proceeded at a reasonable rate in 
a multi-well plate assay, we measured cleavage rates in a stopped-flow fluorometer.  As 
one can see in Figure 3.5, while both peptides give usable data, the change in FRET ratio 
is two-fold greater for the Aad peptide than the Acd peptide. 
 Site-specific genetic incorporation of Aad requires a tRNA synthetase, or RS, that 
efficiently and selectively adenylates Aad and then charges an orthogonal tRNA with this 
activated Aad ester.17  As a first step toward achieving an AadRS, we tested Acd and Aad 
adenylation by AcdRS1 (also referred to as clone G2), a permissive Methanocaldococcus 
jannaschii TyrRS derivative that incorporates Acd, and also incorporates N-phenyl p-
aminophenylanine (Npf) and 4-(2′-bromoisobutyramido) phenylalanine (Brb).46, 61, 64, 88 
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Using a purified form of AcdRS1 in a Malachite green assay that we have previously used 
to characterize the relative activity of the enzyme toward Acd and Npf, we find that Aad is 
activated by AcdRS1, although less efficiently than Acd.88 (Figure 3.6)  These results can 
be understood with a simple model in which Aad is aligned with Acd in our published 
AcdRS1 docking model, based on the crystal structure of AcdRS1 with Brb.64, 88 As one 
can see in Figure 3.6, the Aad exocyclic amine makes contact with the sidechains of 
Val164 and Ala167.  Thus, mutation of these residues to smaller or more polar residues 
may improve Aad charging.  Generating a library of randomized mutants of the 164-167 
loop, followed by selection of the most active clones, is also likely to result in an efficient 
AadRS for in vivo incorporation of Aad. 
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Figure 3.6 Aad Activation by AcdRS1.  Left: Acd and Aad adenylation measured based on 
inorganic pyrophosphate (PPi) formation in an enzyme-coupled Malachite green assay.  Control 
experiments lacking ATP show that the low levels of Aad activity are significant.  Right: Aad 
docked in the AcdRS1 active site by alignment with Acd in an energy-minimized model generated 
from AcdRS1 PDB coordinates 4PBR 
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Conclusions 
We can draw several conclusions from our results.  Firstly, as anticipated from 
previous literature reports, we are able to modulate the fluorescence of the acridone core 
through relatively simple substitutions.  These substitutions, introduced through direct 
modification of acridone or through cross-coupling and cyclization, are compatible with 
eventual usage in generating Acd amino acid derivatives.  Secondly, the close correlation 
(% differences lex: 2.35, lem: 2.40) between our calculated and observed absorption and 
emission spectra give us confidence that we can predict the spectra for acridone derivatives, 
providing guidance for future synthetic efforts.  This will be particularly valuable for 
targeting multiply-substituted derivatives, where the number of possibilities is 
geometrically larger and the synthesis will be more challenging.  Finally, Aad appears to 
be superior to Acd for several fluorescence applications.  As demonstrated here, the red-
shifted emission of Aad provides superior dynamic range in ratiometric FRET 
measurements with an Mcm donor.  Furthermore, its absorption and emission wavelengths 
make Aad amenable to use in microscopy applications using typical filter sets for cyan 
fluorescent protein excitation and yellow fluorescent protein emission.  Aad can also serve 
as a FRET donor to red wavelength dyes such as indodicarbocyanine or sulforhodamine 
G.107 Using the strategy outlined here, we can further improve the spectroscopic properties 
of Aad, such as its relatively low quantum yield.  While Aad can be incorporated into 
peptides, and native chemical ligation can be used for incorporation into proteins if desired, 
our ultimate goal is genetic incorporation of Acd derivatives.  Our initial in vitro activity 
results for Aad are very promising, and computational models based on the crystal structure 
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of AcdRS1 indicate that we may be able to obtain an efficient AadRS with just one or two 
mutations.  These rationally-designed efforts, as well as screening of random mutant 
libraries, are currently under way.  If we can successfully generate an AadRS, this would 
enable the furthest red-shifted fluorescent amino acid to be genetically incorporated in 
living cells. 
 
Experimental Methods 
General Information 
Materials 
L-Tyrosine, thionyl chloride, di-tert-butyl dicarbonate (Boc2O), methyl 2-amino 
benzoate, and phenylsepharose CL-4B resin were purchased from Sigma-Aldrich (St. 
Louis, MO, USA).  N-Phenyl-bis(trifluoromethane sulfonimide) was purchased from 
Oakwood Chemical (West Columbia, SC, USA). Acridin-9(10H)-one, 2-aminoacridin-
9(10H)-one, 2-methoxyacridin-9(10H)-one, and 3-Methyl-2-aminonaphthoic acid were 
purchased from Sigma-Aldrich. Nα-Fmoc-7-methoxycoumarin-4-yl-alanine (Mcm) was 
purchased from Bachem (Torrence, CA, USA).  All other Fmoc protected amino acids and 
peptide coupling reagents, as well as Rink amide resin, were purchased from EMD 
Millipore (Billerica, MA, USA).  Piperidine was purchased from American Bioanalytical 
(Natick, MA, USA).  Milli-Q filtered (18 MΩ) water was used for all solutions (Millipore; 
Billerica, MA, USA).  All other reagents and solvents were purchased from Fisher 
Scientific or Sigma-Aldrich unless otherwise specified. 
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Instruments 
Low resolution electrospray ionization mass spectra (ESI-LRMS) were obtained on 
a Waters Acquity Ultra Performance LC connected to a single quadrupole detector (SQD) 
mass spectrometer (Milford, MA, USA). Accurate mass measurement analyses were 
conducted on either a Waters GCT Premier, time-of-flight, GCMS with electron ionization 
(EI), or an LCT Premier XE, time-of-flight, LCMS with electrospray ionization (ESI).  The 
signals were measured against an internal lock mass reference of perfluorotributylamine 
(PFTBA) for EI-GCMS, and leucine enkephalin for ESI-LCMS.  UV-Vis absorption 
spectra were acquired on a Hewlett-Packard 8452A diode array spectrophotometer 
(currently Agilent Technologies; Santa Clara, CA, USA).  Fluorescence spectra were 
acquired on a Photon Technologies International (PTI) QuantaMaster40 fluorometer 
(currently Horiba Scientific, Edison, NJ, USA).  Nuclear magnetic resonance (NMR) 
spectra were obtained on a Bruker DRX 500 MHz instrument (Billerica, MA, USA).  
Analytical HPLC was performed on an Agilent 1100 Series HPLC system.  Preparative 
HPLC was performed on a Varian Prostar HPLC system (currently Agilent Technologies).  
HPLC columns were purchased from W. R. Grace & Company (Columbia, MD, USA).  
Matrix-assisted laser desorption/ionization mass spectra (MALDI-MS) were collected with 
a Bruker Ultraflex III MALDI-TOF/TOF mass spectrometer (Billerica, MA).  Stopped 
flow fluorescence measurements were made on a KinTek AutoSF-120 instrument (Snow 
Shoe, PA, USA). 
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Chemical Synthesis 
2-Nitroacridin-9(10H)-one (6) and 4-nitroacridin-9(10H)-one (7)  
 
Acridone (5, 50 mg, 0.25 mmol) in 36% acetic acid (250 µL) was stirred vigorously at 50 
°C.  Then glacial acetic acid (500 µL) and 70 % nitric acid (250 µL) were added (Table S1, 
entry 2). The reaction mixture was stirred for 1 h at 50 °C.  The mixture was then poured 
into ice-water (10 mL), neutralized with K2CO3, and extracted with EtOAc three times, 
resulting in a yellow precipitate in the aqueous layer.  The yellow solid in the aqueous layer 
was filtered off, washed thoroughly with water and EtOAc, and dried overnight.  Dried 
solid was then recrystallized in boiling ethanol to give 6 (30 mg, 49% isolated yield).  The 
organic layer was extracted, dried with anhydrous Na2SO4, and concentrated in vacuo.  The 
crude mixture was purified by flash column chromatography to give 7 (6 mg, 10% isolated 
yield). 
2-Nitroacridin-9(10H)-one (6) HRMS (ESI) calculated for C13H9N2O3+ is 241.0613, 
[M+H]+ found  241.0627. 1H NMR (500 MHz, DMSO-d6) δH: 12.34 (s, 1H), 8.98 (d, 1H, 
J = 2.6 Hz), 8.42 (dd, 1H, J = 9.5, 2.7 Hz), 8.23 (d, 1H, J = 8.2 Hz), 7.79 (t, 1H, J = 7.5 
Hz), 7.60 (dd, 2H, J = 25.3, 9.0 Hz), 7.34 (t, 1H, J = 7.3 Hz)    13C NMR (100 MHz, DMSO-
d6) δC: 177.1, 145.7, 141.8, 141.1, 135.0, 127.8, 126.7, 123.7, 123.4, 121.5, 120.0, 119.8, 
119.2 
O
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N
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4-Nitroacridin-9(10H)-one (7) HRMS (ESI) calculated for C13H9N2O3+ is 241.0613 
[M+H]+ found 241.0625. 1H NMR (500 MHz, DMSO-d6) δH:  11.47 (s, 1H), 8.69 – 8.66 
(m, 2H), 8.22 (dd, 1H, J = 8.1, 1.5 Hz), 8.07 (dt, 1H, J = 8.4, 0.7 Hz), 7.81 (ddd, 1H, J = 
8.5, 7.0, 1.6 Hz), 7.44 – 7.37 (m, 2H). 13C NMR (500 MHz, DMSO-d6) δC: 176.5, 140.8, 
136.0, 135.5, 135.3, 135.1, 132.2, 126.4, 123.9, 123.7, 121.3, 120.6, 119.9 
 
 
 
Table 3.2 Screening of acridone nitration conditions 
Entry AcOH (%) HNO3 (%) 5 (%) 6 (%) 7 (%) 
1 75 17.5 5 74 21 
2 59 17.5 10 61 29 
3 43 17.5 7 68 25 
4 27 17.5 98 2 0 
5 75 12.5 11 50 38 
6 59 12.5 10 55 35 
7 43 12.5 87 10 3 
8 27 12.5 98 1.5 0.5 
Each reaction was performed on 50 mg (0.25 mmol) 5 following the general experimental procedure 
described above. Yields calculated based on the area of corresponding HPLC chromatogram peak (100% = 
area of 5 + 6 + 7). 
(Note: The screening of nitration conditions was done by Joomyung V. Jun) 
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Figure 3.7 Screening of acridone nitration conditions. 
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2-Aminoacridin-9(10H)-one (8) and 4-aminoacridin-9(10H)-one (9) 
 
Reduction of 2-nitroacridone (6) to form 2-aminoacridone (8) was preformed to test 
conditions for the reduction of nitroacridonylalanine (7) to form aminoacridonylalanine 
(4). 
 
Condition 1 (without NaOH): To a stirred suspension of 2-nitroacridin-9(10H)-one (6, 4.0 
mg, 0.016 mmol) in ethanol (1.3 mL), a solution of sodium sulfide nonahydrate (110 mg, 
0.46 mmol) in water (2.0 mL) was added. The reaction was refluxed for 20 h. Resulting 
analytical HPLC data of the crude, showed that there was no reaction. 
 
Condition 2 (with NaOH): Subsequent reduction to 2-aminoacridin-9(10H)-one (8) was 
tried under alkaline condition (condition 2). To a stirred suspension of 2-aminoacridin-
9(10H)-one (8), a premixed solution of sodium sulfide nanhydrate (110 mg, 0.46 mmol) 
and sodium hydroxide (26 mg, 0.65 mmol) in water (2.0 mL) was added. After refluxing 
the reaction mixture for 20 h, 2-nitroacridone (6) was almost completely reduced to 2-
aminoacridone (8, 84 % HPLC yield) with a trace amount of starting material. 
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4-nitroacridin-9(10H)-one (7, 4.0 mg, 0.016 mmol) was also reduced under basic solution 
(condition 2) to give 4-aminoacridin-9(10H)-one (9, 80 % HPLC yield). HPLC yields were 
obtained by using 2-aminoacridone or 4-aminoacridone as a standard. 
 
 
 
 
Figure 3.8. Screening of 2- and 4-Nitroacridone reduction conditions. 
(Note: The screening of 2- and 4-nitroacridone reduction conditions was done by Joomyung V. Jun) 
 
 
 
 
 
6
Reduction	of	6	(condition	1)
Reduction	of	6	(condition	2)
8	(standard)
Reduction	of	7	(condition	2)
7	
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4-Aminoacridin-9(10H)-one (9) 
 
 
 
4-Nitroacridin-9(10H)-one (7,0.040 g) was dissolved in 10 mL MeOH and 5 mL 
CH2Cl2.  Pd/C (20 mg) was added to the flask and it was capped with rubber septum.  The 
reaction flask was evacuated and back-filled with H2 gas from a balloon three times.  The 
reaction was stirred at room temperature overnight.  Then, the crude reaction was filtered 
through Celite to remove the Pd/C.  The Celite was washed with CH2Cl2.  The filtrate was 
concentrated and purified by flash column chromatography (5:4:1 CH2Cl2/EtOAc/MeOH).  
4-aminoacridin-9(10H)-one (9) was obtained in 29% isolated yield (10 mg).  HRMS (ESI) 
m/z calculated for C13H30N2O+ [M+H]+ is 211.0871, [M+H]+ found 211.0861. 1H NMR 
(500 MHz, DMSO-d6) δH: 10.69 (1 H, s), 8.16 (1 H, d, J 8.1), 7.69 – 7.63 (2 H, m), 7.50 (1 
H, p, J 3.6), 7.19 (1 H, tt, J 6.7, 2.9), 6.98 – 6.93 (2 H, m), 5.56 (2 H, s). 13C NMR (126 
MHz, DMSO-d6) δC: 177.36, 141.03, 137.26, 133.35, 130.04, 126.27, 121.85, 121.80, 
121.22, 120.38, 117.95, 116.23, 113.81. 
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4-Fluoroacridin-9(10H)-one (15) 
 
 
 
1-Bromo-2-fluorobenzene (11, 219 µL, 2.0 mmol) was added to 10 mL degassed 
toluene in a dried round-bottom flask, followed by methyl 2-aminobenzoate (311 µL, 2.4 
mmol).  The solution was degassed with Ar for 5 min.  Then palladium(II) acetate (0.018 
g, 0.08 mmol), and racemic 2,2′- bis(diphenyl-phosphino)-1,1′-binaphthyl (rac-BINAP, 
0.100 g, 0.16 mmol) were added to the flask.  Cesium carbonate (0.912 g, 2.80 mmol) was 
ground and added to the flask.  The flask was then fitted with a reflux condenser and heated 
to 115 °C for 24 h.  After the solution was allowed to cool to ambient temperature, the 
contents were filtered through a short plug of silica gel using CH2Cl2 to transfer the material 
to the silica (50 mL), and then ethyl acetate (100 mL) was used to elute the product.  The 
clarified solution was then concentrated under reduced pressure and further purified by 
flash column chromatography (9:1 Hexane/EtOAc) to afford 0.4211 g (86%) of methyl 2-
((2-fluorophenyl)amino)benzoate (13). 
 Methyl 2-((2-fluorophenyl)amino)benzoate (13) was dissolved in 4 mL THF in a 
flask and then a LiOH solution (0.206 g in H2O 2 mL) was added.  The reaction mixture 
was refluxed at 80 °C for 1 h and then cooled to room temperature.  The organic solvent 
was evaporated and the pH of the aqueous phase was adjusted to 6.0 with 6 M HCl.  The 
Br
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N
H
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precipitate was collected and dried under vacuum overnight giving 2-((2-
fluorophenyl)amino)benzoic acid (0.2056 g, 52%). 
 7.0 g of polyphosphoric acid (PPA) was added to a round-bottom flask with a stir 
bar and heated to 135 °C in an oil bath.  2-((2-Fluorophenyl)amino)benzoic acid (0.2056 
g, 0.89 mmol) was added to the flask and stirred for 16 h.  Then, 10 mL water was slowly 
added and the reaction allowed to cool to 60 °C.  After stirring for 1 h at 60 °C, the reaction 
was cooled to ambient temperature.  Insoluble impurities were removed by vacuum 
filtration and the pH of the clarified solution was adjusted to 6.5 by addition of 8 M NaOH.  
Then, the solution was cooled to 4 °C for precipitation for about 4 h.  The yellow precipitate 
was collected by vacuum filtration and dried overnight, affording 0.1758 g of 4-
fluoroacridin-9(10H)-one (15, 93%).  HRMS (ESI) m/z calculated for C13H8FNO is 
213.0590, [M+H]+ found 213.0585. 1H NMR (500 MHz, DMSO-d6) δH: 11.64 (1 H, s), 
8.20 (1 H, dd, J 8.2, 1.5), 8.01 (1 H, dd, J 8.2, 1.3), 7.78 (1 H, d, J 8.2), 7.72 (1 H, ddd, J 
8.4, 6.8, 1.6), 7.64 (1 H, ddd, J 11.6, 7.9, 1.4), 7.29 – 7.24 (1 H, m), 7.19 (1 H, td, J 7.9, 
4.8).13C NMR (126 MHz, DMSO-d6) δC: 176.49 (d, J 2.8), 151.52 (d, J 246.4), 141.11, 
134.10, 130.71 (d, J 13.3), 126.31, 122.85 (d, J 1.9), 123.62 – 120.56 (m), 120.97, 120.62 
(d, J 6.9), 119.92 – 116.55 (m). 
 
4-Methoxyacridin-9(10H)-one (16) 
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Degassed toluene (10 mL) was added to 2-bromoanisole (12, 249 µL, 2.0 mmol) in 
a dried round-bottom flask, followed by methyl 2-aminobenzoate (311 µL, 2.4 mmol).  The 
solution was degassed with Ar for 5 min.  Then, palladium(II) acetate (0.018 g, 0.08 mmol), 
and rac-BINAP (0.100 g, 0.16 mmol) were added to the flask.  Cesium carbonate (0.912 
g, 2.80 mmol) was ground and added to the flask.  The flask was then fitted with a reflux 
condenser and heated to 115 °C for 24 h.  After the solution was allowed to cool to ambient 
temperature, the contents were filtered through a short plug of silica gel using CH2Cl2 to 
transfer the material to the silica (50 mL), and then ethyl acetate (100 mL) was used to 
elute the product.  The clarified solution was then concentrated under reduced pressure and 
further purified by flash column chromatography (9:1 Hexane/EtOAc) afforded methyl 2-
((2-methoxyphenyl)amino) benzoate (14, 0.400 g, 78%). 
 A solution of 13.5 M sulfuric acid (5 mL) was added to a flask containing methyl 
2-((2-methoxyphenyl)amino) benzoate (14, 0.40 g, 1.55 mmol).  The flask was then fitted 
with a reflux condenser and heated to 115 °C for 3 h in an oil bath.  15 mL water was then 
added to the flask and allowed to stir for 15 min.  The reaction was then removed from the 
hot oil bath and allowed to cool down. The precipitate formed was then collected with a 
Buchner funnel.  The filtrate was extracted with CH2Cl2 (3 x 40 mL).  The organic phase 
was dried with MgSO4 and evaporated. The crude product was then purified by flash 
column chromatography (99.5:0.5 CH2Cl2/EtOH) to afford 0.334 g (96%) of 4-
methoxyacridin-9(10H)-one (16).  HRMS (ESI) calculated for C14H11NO2 is 225.0790, 
[M+H]+ found 225.0808. 1H NMR (500 MHz, DMSO-d6) δH: 11.18 (1 H, s), 8.18 (1 H, dd, 
J 8.1, 1.7), 7.90 (1 H, d, J 8.5), 7.77 (1 H, dd, J 8.2, 1.3), 7.67 (1 H, ddd, J 8.5, 6.8, 1.7), 
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7.30 (1 H, dd, J 7.9, 1.4), 7.22 (1 H, ddq, J 8.1, 6.9, 1.1), 7.16 (1 H, td, J 8.0, 2.1), 4.01 (3 
H, d, J 2.1).13C NMR (126 MHz, DMSO-d6) δC: 176.96, 148.21, 141.04, 133.47, 132.23, 
126.11, 121.63, 121.49, 120.92, 118.68, 117.51, 112.74, 56.62. 
 
Methyl 3-amino-2-naphthoate (17)  
 
3-Amino-2-naphthoic acid 1.0010 g (5.35 mmol) was added to an oven-dried flask 
and dissolved in methanol (15 mL).  Concentrated H2SO4 5 mL was then gradually added. 
The flask was connected to a condenser, and the reaction was refluxed at 100 oC overnight.  
After cooling the reaction, saturated NaCO33 was added to the crude mixture, and extracted 
with CH2Cl2 (3 x 50mL).  The combined organic layer was dried with MgSO4, filtered, 
evaporated, and dried under vacuum overnight.  Methyl 3-amino-2-naphthoate (17) was 
obtained as a white solid (0.8085 g, 75%). HRMS (ESI) calculated for C12H11NO2+ is 
201.0790, [M+H]+ found 201.0785. 1H NMR (500 MHz, CDCl3) δ H: 8.48 (1 H, d, J 2.3), 
7.72 – 7.66 (1 H, m), 7.53 – 7.46 (1 H, m), 7.38 (1 H, ddt, J 8.6, 5.2, 1.7), 7.20 – 7.13 (1 
H, m), 6.94 (1 H, d, J 2.3), 5.55 (2 H, s), 3.93 (3 H, s). 13C NMR (126 MHz, CDCl3) δC: 
168.20, 145.91, 140.97, 137.28, 133.36, 129.14, 128.69, 125.97, 125.08, 122.42, 114.67, 
109.89, 51.83. 
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Benzo[b]acridin-12(5H)-one (18) 
 
Methyl 3-amino-2-naphthoate (17) (0.241 g, 1.20 mmol) was dissolved in 10 mL 
degassed toluene in a dried sealed tube and bromobenzene (S2, 105 µL, 1.0 mmol) was 
added.  Then palladium(II) acetate (0.009 g, 0.04 mmol), and rac-BINAP (0.050 g, 0.08 
mmol) were added to the tube.  Cesium carbonate (0.456 g, 1.40 mmol) was added to the 
tube.  The reaction mixture was capped and heated to 115 °C for 24 h.  After the solution 
was allowed to cool to ambient temperature, the contents were filtered through a short plug 
of silica gel using CH2Cl2 to transfer the material to the silica and then ethyl acetate (100 
mL) was used to elute the product.  The clarified solution was then concentrated under 
reduced pressure and further purified by flash column chromatography (9:1 
Hexane/EtOAc) to afford 0.2311 g (83%) of methyl 3-(phenyl amino)-2-naphthoate (S3). 
Methyl 3-(phenylamino)-2-naphthoate was dissolved in THF (4 mL) and MeOH (2 
mL) in a 25 mL flask and then a LiOH solution (0.0527 g in 2 mL H2O) was added.  The 
reaction mixture was refluxed at 90 °C for 1 h and then cooled to room temperature.  The 
organic solvent was evaporated, and the pH of the aqueous phase was adjusted to 6.0 with 
6 M HCl.  The precipitate was collected and dried under vacuum overnight, giving 3-
(phenylamino)-2-naphthoic acid (0.1131 g, 98%). 
 6.56 g PPA was added to a 25 mL round-bottom flask with a stir bar.  The flask 
was heated to 125 °C in an oil bath.  Then 3-(phenylamino)-2-naphthoic acid (0.1131 g, 
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0.43 mmol) was added to the flask and it was stirred for 2 h.  Water (10 mL) was slowly 
added and the reaction allowed to cool to 60 °C.  After stirring for 1 h, the reaction was 
cooled to ambient temperature.  Insoluble impurities were removed by vacuum filtration 
and the pH of the clarified solution was adjusted to 7.0 by addition of 10 M NaOH.  The 
yellow precipitate was collected by vacuum filtration and dried overnight affording 0.090 
g of benzo[b]acridin-12(5H)-one (18, 85%). HRMS (ESI) calculated for C17H11NO+ is 
245.0841, [M+H]+ found 245.0863. 1H NMR (500 MHz, Methanol-d4) δH: 8.97 (1 H, s), 
8.34 (1 H, dd, J 8.1, 1.5), 8.05 (1 H, d, J 8.5), 7.91 – 7.88 (2 H, m), 7.72 (1 H, ddd, J 8.6, 
7.0, 1.6), 7.55 (1 H, ddd, J 8.3, 6.5, 1.2), 7.48 (1 H, d, J 8.3), 7.40 (1 H, ddd, J 8.0, 6.6, 
1.2), 7.22 (1 H, ddd, J 8.1, 6.9, 1.1). 13C NMR (126 MHz, DMSO-d6) δ C: 178.20, 142.18, 
138.90, 135.86, 134.21, 129.77, 128.53, 127.85, 127.37, 126.72, 126.56, 124.84, 121.42, 
120.28, 118.4, 117.2, 112.5. 
 
 
4-Fluorobenzo[b]acridin-12(5H)-one (19) 
 
 
Methyl 3-amino-2-naphthoate (17) (0.241 g, 1.20 mmol) was dissolved in 10 mL 
degassed toluene in a dried sealed tube, followed by addition of 1-bromo-2-fluorobenzene 
(11) (109 µL, 1.0 mmol).  Then palladium(II) acetate (0.009 g, 0.04 mmol), and rac-BINAP 
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(0.050 g, 0.08 mmol) were added to the tube.  Cesium carbonate (0.456 g, 1.40 mmol) was 
added to the tube.  The reaction mixture was capped and heated to 115 °C for 24 h.  After 
the solution was allowed to cool to ambient temperature, the contents were filtered through 
a short plug of silica gel using CH2Cl2 to transfer the material to the silica and then ethyl 
acetate (100 mL) was used to elute the product.  The clarified solution was then 
concentrated under reduced pressure and further purified by flash column chromatography 
(9:1 Hexane/EtOAc) to afford 0.2648 g (90%) of 3-((2-fluorophenyl)amino)-2-naphthoate 
(S4). 
Methyl 3-(phenylamino)-2-naphthoate was dissolved in THF (4 mL) and MeOH (2 
mL) in a 25 mL flask and then a LiOH solution was added (0.0527 g in 2 mL H2O).  The 
reaction mixture was refluxed at 90 °C for 1 h and then cooled to room temperature.  The 
organic solvent was evaporated and the pH of the aqueous phase was adjusted to 6.0 with 
6 M HCl.  The precipitate was collected and dried under vacuum overnight giving 3-
(phenylamino)-2-naphthoic acid 0.1131 g (98%). 
 PPA (6.56 g) was added to a 25 mL round-bottom flask with a stir bar.  The flask 
was heated to 125 °C in an oil bath.  3-(phenylamino)-2-naphthoic acid 0.1131 g (0.43 
mmol) was added to the flask and stirred for 2 h.  Then, 10 mL water was slowly added 
and the reaction allowed to cool to 60 °C.  After stirring for 1 h, the reaction was cooled to 
ambient temperature.  Insoluble impurities were removed by vacuum filtration and the pH 
of the clarified solution was adjusted to 7.0 by addition of 10 M NaOH.  The yellow 
precipitate was collected by vacuum filtration and dried overnight affording 0.090 g of 
benzo[b]acridin-12(5H)-one (19, 85 %).  HRMS (EI) calculated for C17H10FNO is 
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263.0746, found 263.0753.  1H NMR (500 MHz, DMSO-d6) δH: 11.52 (1 H, s), 8.91 (1 H, 
s), 8.18 (1 H, s), 8.14 (1 H, d, J 8.3), 8.04 (1 H, d, J 8.1), 7.93 (1 H, d, J 8.4), 7.66 (2 H, 
dd, J 11.6, 7.7), 7.58 (1 H, dd, J 8.5, 6.6), 7.43 (1 H, q, J 7.4, 6.2), 7.15 (1 H, td, J 7.9, 4.8). 
13C NMR (126 MHz, DMSO-d6) δC: 177.84, 152.18, 150.23, 137.86, 136.21, 131.77, 
130.05, 129.05, 128.37, 127.72, 126.96, 124.84, 122.42, 121.48, 119.73, 118.94, 113.46. 
 
4-Methoxybenzo[b]acridin-12(5H)-one (20) 
 
Methyl 3-amino-2-naphthoate (17, 0.241 g, 1.20 mmol) was dissolved in 10 mL 
degassed toluene in a dried sealed tube, followed by adding 2-bromoanisole (12, 125 µL, 
1.0 mmol).  Then palladium(II) acetate (0.009 g, 0.04 mmol), and rac-BINAP (0.050 g, 
0.08 mmol) were added to the tube.  Cesium carbonate (0.456 g, 1.40 mmol) was added to 
the tube.  The reaction mixture was capped and heated to 115 °C for 24 h.  After the solution 
was allowed to cool to ambient temperature, the contents were filtered through a short plug 
of silica gel using CH2Cl2 to transfer the material to the silica and then ethyl acetate (100 
mL) was used to elute the product.  The clarified solution was then concentrated under 
reduced pressure and further purified by flash column chromatography (90:10 
Hexane/EtOAc) to afford 0.2094 g (68%) of methyl 3-((2-methoxyphenyl)amino)-2-
naphthoate (S5). 
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Methyl 3-((2-methoxyphenyl)amino)-2-naphthoate (S5, 0.1943 g, 0.632 mmol) 
was dissolved in THF (5 mL) and MeOH (3 mL) in a 25 mL flask and then a LiOH solution 
was added (0.0757 g in 3 mL H2O).  The reaction mixture was refluxed at 90 °C for 1 h 
and then cooled to room temperature.  The organic solvent was evaporated and the pH of 
the aqueous phase was adjusted to 6.0 with 6 M HCl.  The precipitate was collected and 
dried under vacuum overnight giving 3-((2-methoxyphenyl)amino)-2-naphthoic acid 
0.1623 g (98%). 
 PPA (6.90 g) was added to a 25 mL round-bottom flask with a stir bar.  The round-
bottom flask was heated to 125 °C in an oil bath.  3-((2-methoxyphenyl)amino)-2-
naphthoic acid 0.1513 g (0.516 mmol) was added to the flask and stirred for 2 h.  Then 10 
mL water was slowly added and the reaction allowed to cool to 60 °C.  After stirring for 1 
h at 60 °C, the reaction was cooled to ambient temperature.  Insoluble impurities were 
removed by vacuum filtration and the pH of the clarified solution was adjusted to 7.0 by 
addition of 10 M NaOH.  The yellow precipitate was collected by vacuum filtration and 
dried overnight affording 01261 g of 4-methoxybenzo [b]acridin-12(5H)-one (20, 89%). 
HRMS (EI) calculated for C18H13NO2 is 275.0946, found 275.0948.  1H NMR (500 MHz, 
DMSO-d6) δH: 11.06 (1 H, s), 8.88 (1 H, s), 8.32 (1 H, s), 8.12 (1 H, d, J 8.3), 7.89 (1 H, d, 
J 8.4), 7.80 (1 H, d, J 8.0), 7.58 – 7.51 (1 H, m), 7.43 – 7.36 (1 H, m), 7.34 – 7.28 (1 H, 
m), 7.12 (1 H, t, J 7.9), 4.03 (3 H, s).13C NMR (126 MHz, DMSO-d6) δC: 178.33, 147.85, 
138.00, 135.99, 133.39, 129.99, 128.73, 128.18, 127.30, 126.96, 124.56, 121.58, 120.05, 
119.82, 117.84, 113.50, 56.64. 
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(S)-2-((tert-butoxycarbonyl)amino)-3-(9-oxo-9,10-dihydroacridin-2-yl)propanoic 
acid (S6) 
 
(S)-2-amino-3-(9-oxo-9,10-dihydroacridin-2-yl) propanoic acid (Acd, 2, 0.050 g, 
0.18 mmol), synthesized as previously described, was dissolved in EtOH (15 mL).46  
Na2CO3 (0.029 g, 0.27 mmol) and di-tert-butyl dicarbonate (Boc2O, 0.059 g, 0.27 mmol) 
was added to the flask.  The reaction was stirred at room temperature for 16 h.  The reaction 
mixture was evaporated and quenched with 0.1 M HCl.  The crude product was extracted 
with CH2Cl2 three times.  The combined organic layers were washed with saturated NaCl 
solution, dried with MgSO4, and evaporated in vacuo.  (S)-2-((tert-butoxycarbonyl)amino)-
3-(9-oxo-9,10-dihydroacridin-2-yl) propanoic acid, Boc-Acd, S6) was obtained (0.064 g , 
93%). 
(S)-2-amino-3-(7-amino-9-oxo-9,10-dihydroacridin-2-yl)propanoic acid (4) 
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To 180 mg (0.64 mmol) of Acd (2) in a 40 mL scintillation vial, glacial acetic acid 
(3 mL) and 70% nitric acid (1 mL) were added.  The reaction mixture was stirred for 2 h 
at 50 °C.  The mixture was cooled to room temperature and cold brine (20 mL) was added 
to precipitate (S)-2-amino-3-(7-nitro-9-oxo-9,10-dihydroacridin-2-yl)propanoic acid (S7).  
The crude yellow precipitate (81 mg, 39% isolated yield; >90% conversion based on 
integration of the HPLC chromatogram, but isolation of pure material was limiting) was 
reduced without further purification.  81 mg S7 (0.247 mmol, 1 equiv) was dissolved in 2 
mL ethanol and 1 mL water in a 20 mL scintillation vial.  In a separate vial, NaOH (333 
mg, 8.3 mmol, 33 equiv) and sodium sulfide nonahydrate (500 mg, 2.08 mmol, 8.4 equiv) 
were mixed in 2 mL of water.  The premixed solution of NaOH and sodium sulfide was 
added to the reaction vial and stirred overnight at 80 oC.  After the reaction was complete, 
the crude solution was purified by ion-exchanged resin and lyophilized to give (S)-2-
amino-3-(7-amino-9-oxo-9,10-dihydroacridin-2-yl)propanoic acid (S)-2-amino-3-(7-
amino-9-oxo-9,10-dihydroacridin-2-yl) propanoic acid (Aad, 4) (63 mg, 86 % yield).  
HRMS (ESI) calculated for C16H16N3O3+ is  298.1192,  found 298.1191. 1H NMR (500 
MHz, D2O) δH: 7.31 (1 H, d, J 2.1), 6.99 (1 H, dd, J 8.5, 2.0), 6.84 – 6.75 (2 H, m), 6.61 (2 
H, dd, J 19.7, 8.6), 4.72 (1 H, d, J 1.1), 3.65 (1 H, dd, J 7.6, 5.6), 2.84 (1 H, dd, J 14.5, 
5.6), 2.72 (1 H, dd, J 14.5, 7.6). 13C NMR (126 MHz, D2O) δC: 176.34, 160.89, 140.29, 
137.79, 133.85, 133.49, 128.21, 125.25, 124.46, 119.41, 117.96, 117.55, 117.43, 107.71, 
56.19, 37.25. 
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(S)-2-((tert-butoxycarbonyl)amino)-3-(7-((tert-butoxycarbonyl)amino)-9-oxo-9,10-
dihydro acridin-2-yl)propanoic acid (Boc2-Aad, S8) 
 
To 90 mg (0.32 mmol, 1 equiv) Acd (2) in a 40 mL scintillation vial, glacial acetic 
acid (1.5 mL) and 70% nitric acid (0.5 mL) were added.  The reaction mixture was stirred 
for 2 h at 50 °C.  The mixture was cooled down room temperature and cold water (5 mL) 
was added to quench the nitration reaction.  For reduction, ethanol (5 mL) was added to 
the crude material followed by addition of premixed NaOH (512 mg, 12.8 mmol, 40 equiv) 
and sodium sulfide nonahydrate (769 mg, 3.2 mmol, 10 equiv) in water (2 mL).  The 
reaction vial was stirred overnight at 80 oC.  After the reaction was judged complete by 
chromatography analysis, the crude solution was cooled to room temperature and quenched 
by adding saturated NaHCO3 (5 mL).  The crude mixture was transferred to a 100 mL 
round bottom flask.  NaHCO3 (900 mg) was added to the reaction mixture and it was stirred 
at room temperature.  Once the pH of the reaction mixture reached pH 8-9, Boc2O (2.1 g, 
9.6 mmol, 30 equiv) was added, and the reaction stirred at room temperature overnight.  
The mixture was then slightly acidified with a saturated NH4Cl solution.  The aqueous 
mixture was extracted with ethyl acetate three times, then the organic layer was collected 
and dried with Na2SO4.  The organic layer was concentrated in vacuo and purified via silica 
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column chromatography (0%-20% MeOH in CH2Cl2) to remove excess t-butanol.  The 
product was obtained and lyophilized to give Boc2-Aad (S8, 79 mg, 50% yield over three 
steps).   
HRMS (ESI) calculated for C26H32N3O7+ is 498.2240, found 498.2230.  1H NMR 
(500 MHz, MeOD) δH: 8.28 (1 H, s), 8.16 (1 H, s), 7.83 (1 H, d, J 8.4 Hz), 7.61 (1 H, d, J 
9.1 Hz), 7.45-7.41 (2 H, m), 4.39 (1 H, br. s), 3.28 (1 H, m), 3.04 (1 H, br. s), 1.55 (9 H, s), 
1.33 (9 H, s), 1.40 (tBuOH residual peak), 3.35 (MeOH solvent residual peak) 13C NMR 
(126 MHz, MeOD) δC: 179.94, 158.19, 155.92, 141.52, 138.92, 136.86, 135.30, 132.84, 
128.37, 122.33, 127.87, 122.33, 121.49, 119.38, 118.82, 115.67, 80.91, 58.07, 39.33, 29.25 
(31.22 residual tBuOH).  See Figure 3.7. 
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Figure 3.9 Boc2-Aad (S8) 1H and 13C NMR spectra in MeOD. 
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Spectroscopic Characterization of Substituted Acridones 
Prior to spectroscopic characterization, stocks of all acridone and benzoacridone 
compounds were prepared in acetonitrile at a concentration of 200 or 300 µM.  All 
absorbance and fluorescence measurements were taken in 1:1 CH3CN/buffer.  Buffers 
include citrate buffer (89.1 mM citric acid 21.8 mM Na2HPO4) pH 2.6, phosphate buffered 
saline (PBS, 137 mM NaCl, 2.7 mM KCl, 10 mM Na2HPO4, 2 mM KH2PO4) pH 7.4, and 
3-(cyclohexylamino)-1-propanesulfonic acid (CAPS) buffer, pH 10.0.  The absorbance and 
emission spectra of all compounds were acquired in 1:1 CH3CN/PBS.  The sensitivity of 
the absorbance and emission to pH was assessed for the parent acridone core as well as the 
4-NH2 and 2-NH2 derivatives in 1:1 CH3CN/citrate and 1:1 CH3CN/CAPS.  Absorbance 
measurements were acquired at concentrations of 75 and 7.5 µM for proper visualization 
of the spectral profile above and below ~300 nm (4-aminoacridone absorbance 
measurements were taken at 7.5 and 0.75 µM). 
 Fluorescence measurements were acquired under identical solution conditions at 
concentrations of 7.5 µM for all compounds, except for the 4-NH2, 2-NO2, and 4-NO2 
derivatives of Acd which were obtained at 75 µM due to a lack of brightness.  Spectra were 
collected using excitation wavelengths matching the maximum absorbance wavelength for 
each analog measured.  The collection window started 15 nm from the excitation 
wavelength and extended to 650 nm.  This window was truncated to no less than a total 
range of 150 nm for more blue shifted chromophores.  All slit widths were set to 1.5 nm 
and spectra were acquired with an integration time of 0.25 sec/nm.  Higher signal-to-noise 
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spectra for the 4-NH2, 2-NO2, and 4-NO2 derivatives were collected keeping all other 
setting the same but adjusting all slit widths to 3 nm. 
 Extinction coefficients were calculated from absorbance measurements collected 
on a Tecan M1000 plate reader (Mannedorf, Switzerland).  Samples containing 100, 80, 60, 
40 and 20 µM chromophore were prepared in 1:1 CH3CN/PBS solution with a total sample 
volume of 100 µL.  Following brief vortexing, samples were loaded into a Corning CoStar 
black, clear bottom, 96-well plate. 
 Absorbance and emission spectra are reported in Figures 3.8 – 3.13.  Emission 
spectra are shown normalized to the acridone emission at 412 nm to approximate quantum 
yields.  The most prominent peak positions are reported along with extinction coefficients 
and these relative emission intensities in Table 3.2.  Calculated spectra (described below) 
are shown for comparison. 
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Table 3.3 Calculated and Observed Photophysical Parameters of Acridone Derivatives. 
  Calculated  Observed 
Compound  lex/ea lem/Int.b  lex/ea lem/Int.b 
Acd 5  253/11.4 00411/1.00  254/5.22 412/1.00 
  364/1.51 434/0.45  382/0.72 435/0.83 
  383/2.43   398/0.70  
2-NO2 6  235/5.32 -  230/3.33 - 
  282/2.53   296/0.87  
  341/1.03   356/0.76  
  408/1.87   402/0.37  
4-NO2 7  243/6.62 -  244/2.81 - 
  292/2.56   266/0.94  
  331/1.27   328/0.58  
  464/2.06   434/0.60  
2-NH2 8  252/4.93 509/0.21  256/3.38 527/0.16 
  278/2.96   278/2.46  
  419/0.47   420/0.52  
4-NH2 9  252/5.74 492/0.59  260/4.19 540/0.01 
  299/1.20   314/0.38  
  400/0.61   400/0.59  
4-F 15  248/12.8 397/0.48  252/4.44 412/0.65 
  365/1.19   378/0.51  
2-OMe S1  251/10.0 444/0.47  252/5.32 447/0.63 
  271/3.61   268/5.38  
  400/0.95   396/0.82  
     414/0.82  
4-OMe 16  249/6.62 421/0.35  256/6.30 431/0.37 
  375/0.62   384/0.69  
Bz 18  234/1.38 495/0.31  222/1.78 507/0.42 
  269/21.7   272/12.7  
  302/1.40   296/2.07  
  446/0.81   438/0.58  
4-F-Bz 19  268/15.3 496/0.24  268/9.96 508/0.21 
  446/0.61   448/0.54  
4-OMe-Bz 20  272/14.0 512/0.25  272/9.42 512/0.14 
  456/0.67   454/0.61  
aExtinction coefficients (e) reported as 104 M-1cm-1. 
bEmission intensity (Int.) normalized the intensity of the highest emission peak of acridone for both 
calculated and observed spectra.  
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Figure 3.10 Acridone (5) spectra. Experimental (solid lines) and calculated (dashed lines) spectra 
and with vibronic transitions to/from lowest excited state (black bars) of 5 at pH 7.4, and 
experimental spectra at pH 2.6 and 10.0. 
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Figure 3.11 2-Aminoacridone (8) spectra. Experimental (solid lines) and calculated (dashed lines) 
spectra and with vibronic transitions to/from lowest excited state (black bars) of 8 at pH 7.4, and 
experimental spectra at pH 2.6 and 10.0. 
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Figure 3.12 4-Aminoacridone (9) spectra. Experimental (solid lines) and calculated (dashed lines) 
spectra and vertical transitions (black bars) of 9 at pH 7.4, and experimental spectra at pH 2.6 and 
10.0. 
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Figure 3.13 2-Nitroacridone (6) and 4-Nitroacridone (7) spectra.  Experimental (solid lines) and 
calculated (dashed lines) spectra and vertical transitions (black bars) of 6 and 7 at pH 7.4. 
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Figure 3.14 2-Fluoroacridone (15), 2-Methoxyacridone (S1), and 4-Methoxyacridone (16) spectra.  
Experimental (solid lines) and calculated (dashed lines) spectra and vertical transitions (black bars) of 
15, S1, and 16 at pH 7.4. 
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Figure 3.15 4-Benzoacridone (18), 4-Fluorobenzoacridone (19), and 4-Methoxybenzoacridone 
(20) spectra.  Experimental (solid lines) and calculated (dashed lines) spectra and vertical 
transitions (black bars) of 18, 19, and 20 at pH 7.4. 
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CHAPTER 4: Toward the Synthesis and in vivo Incorporation of Acridone 
Derivatives into Proteins 
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Introduction 
 In order to improve the properties of the fluorescent amino acid acridonylalanine 
(Acd) and provide other amino acids with complementary properties, we have prepared a 
series of acridone derivatives and studied their photophysical properties.108 2-
Aminoacridone has a red-shifted emission and larger Stokes shift than acridone. Therefore, 
it provides a superior Förster resonance energy transfer (FRET) partner for 7-
methoxycoumarin (Mcm) in fluorescence spectroscopy studies. The amino acid form, 
aminoacridonylalanine (Aad, 1), has also been synthesized to test applications in FRET-
based proteolysis experiments and preliminary in vitro tRNA charging activity. In these 
studies, Aad was synthesized through the nitration reaction of Acd, followed by reduction 
with Na2S under basic conditions. However, the nitration reaction gave multiple products 
corresponding to the 5-nitro, 7-nitro (i.e. Aad), and 5-,7-dinitro derivatives of Acd. Since 
it was difficult to control the selectivity of the reaction or separate these side products, we 
pursued an alternate synthetic route, shown in Scheme 4.1. 
 
Scheme 4.1 The alternative synthesis of 2-aminoacridone (1, Aad) 
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Improving the Synthesis of 2-aminoacridone amino acid (Aad) 
 The alternate route uses the same tert-butoxycarbonyl (Boc) protected tyrosine 
methyl ester, triflated for cross-coupling (2), that we used to produce Acd.46  This 
compound is then subjected to a C-N cross-coupling reaction with an aniline derivative 
that already bears the amino group for Aad formation, followed by our usual acid-catalyzed 
ring-closing reaction. We utilized the Buchwald-Hartwig amination strategy to couple 
Boc-Tyr(OTf)-OMe (2) and tert-butyl (4-amino-3-cyanophenyl)carbamate (3).109 The 
cross-coupling product (4) contains a cyano group which can then be hydrolyzed to the 
carboxylic acid by H2SO4. The sulfuric conditions not only hydrolyze the cyano group, but 
also catalyze Friedel-Crafts ring-closing, and cleave both the Boc group and methyl ester 
to achieve the Aad product. 
 We took advantage of University of Pennsylvania High Through Experimentation 
(HTE) Center to screen Buchwald-Hartwig Pd-mediated cross-coupling amination 
conditions. Different palladium catalysts, bases, solvents were tested. We selected 
Buchwald Pd pre-catalysts as a choice of catalytic system.110-111 For these pre-catalysts, 
palladium has already been bound to the biarylphosphine ligands and their use ensures the 
efficient formation of the active catalytic species so that we do not need to vary Pd-to-
ligand ratios. These catalysts are also air, moisture, and thermally-stable and exhibit good 
solubility in organic solvent. 3.0 equivalents of bases NaOtBu and Cs2CO3 were used 
relative to starting material (2). The reaction was stirred in either dioxane or toluene at 100 
oC for 16 h. The screening results are shown in Figure 4.1. 
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Figure 4.1 Cross-coupling Screening results. Coupling of compounds 2 and 3 carried in 24 well 
plates with varying solvents, bases, and Pd pre-catalyst. Conversion determined as the ratio of the 
product peak and a standard peak in HPLC chromatograms.  Catalysts defined in Experimental 
Methods section. 
 
 From these cross-coupling reaction screening results, we selected the best yielding 
condition which is the reaction with BrettPhos-Pd G1, using Cs2CO3 as base in either 
toluene or dioxane. We then increased the scale of the reaction to test this HTE result, 
followed by acid-catalyzed ring-closing reaction to obtain Aad in 32 % overall yield. 
 
Improving the Synthetase Activation of Aad 
 To be used for site-specific in vivo protein labeling, Aad must be charged onto an 
orthogonal tRNA by an aminoacyl tRNA synthetase (RS).  Our initial test of aminoacyl 
adenylate activation of Aad by the permissive, first generation RS AcdRS1 (G2) showed 
that Aad was activated at 12% of the level of Acd activation.  Further testing of other RS 
constructs showed that a second generation RS evolved for improved Acd incorporation, 
AcdRS2b (A9), activated Aad at 36% of the level of Acd, making it promising for in vivo 
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incorporation of Aad in bacteria without further modification.  Unfortunately, initial tests 
for Aad incorporation in calmodulin and α-synuclein yielded very low protein quantities 
with no indication of Aad fluorescence (data not shown).  Therefore, we are currently 
pursuing random selection of RS clones with Aad incorporation activity in collaboration 
with Ryan Mehl at Oregon State University as well as rationally designed mutagenesis of 
residues 164-167, which have been identified as potentially blocking Aad binding in the 
A9 active site in homology models based on the AcdRS1 (G2) crystal structure. 
 
 
 
 
 
 
 
 
Figure 4.2 Aad Activation by AcdRS2b (A9).  Left: Acd and Aad adenylation measured based on 
inorganic pyrophosphate (PPi) formation in an enzyme-coupled Malachite green assay.  Right: Aad 
docked in the AcdRS2b active site by alignment with Acd in an energy-minimized model generated 
from AcdRS1 PDB coordinates 4PBR.64 
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Additional Acridone Core Derivatives 
 We have shown that the 2-aminoacridone core has valuable properties such as a 
red-shift emission and a large Stokes shift. However, it also suffers from a low quantum 
yield relative to Acd (0.16 vs. 0.95 in water).108  Therefore, we were interested in achieving 
brighter Aad analogs. It has been shown for many fluorophores that dialkylation of a 
pendant amino group can modulate absorption and emission spectra by sterically restricting 
orbital alignment and increase the quantum yield by reducing internal charge transfer that 
can lead to non-radiative relaxation.112-114  Recently, Lavis and coworkers have shown that 
this effect can be improved by using an azetidine ring to further restrict orbital alignment 
leading to quenching.115 To determine whether either of these effects could be exploited to 
improve the brightness of Aad, we synthesized two aminoacridone derivatives: 2-
(dimethylamino)acridin-9(10H)-one (5) and 2-(azetidin-1-yl)acridin-9(10H)-one (6), 
shown in Figure 4.3. 
 
 
 
 
 
 
 
Figure 4.3 Structure of 2-(dimethylamino)acridin-9(10H)-one (5, Dad) and 2-(azetidin-1-
yl)acridin-9(10H)-one (6, AzAcd) 
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 To synthesize the Dad (5), we have utilized the reductive amination reaction by 
reacting 2-aminoacridone (Aad) with formaldehyde (CH2O), followed by sodium 
cyanoborohydride (NaBH3CN) to give the dimethylated product, 2-(dimethylamino)acridin-
9(10H)-one (5) along trimethylated 2-(dimethylamino)-10-methylacridin-9(10H)-one as 
side product, which can then be separated by column chromatography. To synthesize 
azetidinyl acridone (AzAcd, 6), we performed Pd-mediated cross-coupling reaction 
between 2-bromoacridin-9(10H)-one (11) and azetidine hydrochloride as described in 
experimental method section. 2-Bromoacridin-9(10H)-one was previously synthesized by 
cross-coupling reaction of 1,4-dibromobenzene (8) and methyl 2-aminobenzoate (9) to 
provide product methyl 2-((4-bromophenyl)amino)benzoate (10). Then saponification with 
LiOH followed by Friedel−Crafts cyclization was used to provide 2-bromoacridin-9(10H)-
one (11). 
 The photophysical properties were then characterized by measuring absorption and 
emission spectra and compared to 2-aminoacridone (Aad, 7) in Figure 4.4. The absorption 
maximum of Dad (5) and AzAcd (6) are not significantly shifted from aminoacridone (7). 
The emission maximum of Dad (5) has red-shifted about 15 nm compared to Aad (7). 
However, the fluorescence intensity of Dad (5) and AzAzd (6) and 3- and 4-fold higher 
than Aad, respectively, at equivalent concentrations. Therefore, these two aminoacridone 
derivatives demonstrated that modification of the amino group can indeed improve the 
brightness of fAad. Thus, we will synthesize Dad and AzAcd amino acid analogs for future 
in vivo incorporation. 
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Figure 4.4 Absorption (top) and emission (bottom) spectrum of Aad, Dad, and AzAcd 
 
Conclusions 
 We have further developed the set of acridone fluorophores to achieve a 
straightforward synthesis of Aad, which has good prospects for in vivo incorporation, as 
well as alkylated Aad core analogs, one of which has slightly improved spectroscopic 
properties.  Future studies will focus on other methods for improving the brightness of Aad 
as well as genetic selection experiments to achieve a highly active RS.  A synthesis of an 
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amino acid analog of Dad and selection of an RS for its incorporation would provide a 
further red-shifted probe, which could function as a FRET acceptor for Acd. 
 
Experimental Method 
General Information 
Materials 
Di-tert-butyl dicarbonate (Boc2O), 2,5-diaminobenzonitriles, 1,4-dibromobenzene 
azetidine hydrochloride, BrettPhos-Pd G1, Cesium carbonate were purchased from Sigma-
Aldrich (St. Louis, MO, USA).  N-Phenyl-bis(trifluoromethane sulfonimide) was 
purchased from Oakwood Chemical (West Columbia, SC, USA). Milli-Q filtered (18 MΩ) 
water was used for all solutions (Millipore, Billerica, MA, USA).  All other reagents and 
solvents were purchased from Fisher Scientific or Sigma-Aldrich unless otherwise 
specified. 
Instruments 
Low resolution electrospray ionization mass spectra (ESI-LRMS) were obtained on 
a Waters Acquity Ultra Performance LC connected to a single quadrupole detector (SQD) 
mass spectrometer (Milford, MA, USA). Accurate mass measurement analyses were 
conducted on either a Waters GCT Premier, time-of-flight, GCMS with electron ionization 
(EI), or an LCT Premier XE, time-of-flight, LCMS with electrospray ionization (ESI).  The 
signals were measured against an internal lock mass reference of perfluorotributylamine 
(PFTBA) for EI-GCMS, and leucine enkephalin for ESI-LCMS.  UV-Vis absorption 
spectra were acquired on a Hewlett-Packard 8452A diode array spectrophotometer 
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(currently Agilent Technologies; Santa Clara, CA, USA).  Fluorescence spectra were 
acquired on a Photon Technologies International (PTI) QuantaMaster40 fluorometer 
(currently Horiba Scientific, Edison, NJ, USA).  Nuclear magnetic resonance (NMR) 
spectra were obtained on a Bruker DRX 500 MHz instrument (Billerica, MA, USA). 
 
Chemical Synthesis 
Synthesis of 2-(dimethylamino)acridin-9(10H)-one 
 
 
 
 
 
2-aminoacridone (7) 15.0 mg (0.071 mmol) was dissolved in concentrated 
CH3COOH 4 mL. The p-formaldehyde (CH2O) 21.3 mg (0.71 mmol) was added to reaction 
flask. Reaction mixture was stirred at room temperature for 15 min. (Color changed from 
yellow to dark red.) Then NaBH3CN 17.9 mg (0.285 mmol) was added to the flask. The 
mixture was allowed to stir at room temperature overnight. Crude mixture was neutralized 
by 6M NaOH and extracted with EtOAc 3 x 20 mL. The combined organic layer was dried 
with Na2SO4 and evaporated. Then purified by flash chromatography column (EtOAC/ 
CH2Cl2/MeOH = 5: 4.5: 0.5) to separate di- and tri- methylated product. The 2-
(dimethylamino)acridin-9(10H)-one (5) was obtained 4 mg as yellow solid. (24 % yield) 
1H NMR (500 MHz, Methanol-d4) δH: 8.33 (dd, J = 8.3, 1.5 Hz, 1H), 7.65 (ddd, J = 8.5, 
N
H
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NCH2O, NaBH3CN
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NH2
CH3COOH
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6.9, 1.5 Hz, 1H), 7.56 (q, J = 1.7 Hz, 1H), 7.51 – 7.45 (m, 3H), 7.22 (ddd, J = 8.1, 6.8, 1.1 
Hz, 1H), 2.99 (d, J = 1.4 Hz, 6H). 13C NMR (126 MHz, Methanol-d4) δC: 180.86 – 174.68 
(m), 146.39, 140.48, 134.16, 132.66, 125.72, 123.19, 121.24, 120.44, 119.44, 117.86, 
116.78, 105.40, 40.01. 
 
 
Synthesis of 2-bromoacridin-9(10H)-one 
 
 
Degassed toluene (10 mL) was added to 1,4-Dibromobenzene (8) 0.236 g (1.0 
mmol) in a dried round-bottom flask, followed by methyl 2-aminobenzoate (9) (162 µL, 
1.25 mmol).  The solution was degassed with Ar for 5 min.  Then, palladium(II) acetate 
(0.025 g, 0.1 mmol), and rac-BINAP (0.093 g, 0.15 mmol) were added to the flask.  Cesium 
carbonate (0.997 g, 3.0 mmol) was added to the flask.  The flask was then fitted with a 
reflux condenser and heated to 60 °C for 24 h.  After the solution was allowed to cool to 
ambient temperature, the contents were filtered through a short plug of silica gel using 
CH2Cl2 to transfer the material to the silica (20 mL), and then ethyl acetate (100 mL) was 
used to elute the product.  The clarified solution was then concentrated under reduced 
pressure and further purified by flash column chromatography (9:1 Hexane/EtOAc) 
afforded methyl 2-((4-bromophenyl)amino) benzoate (10) 0.146 g (48% yield). 
Br
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 Methyl 2-((4-bromophenyl)amino)benzoate 0.0864 g (0.28 mmol) was dissolved 
in THF 5 mL. LiOH 0.0335 g (1.40 mmol) was dissolved in H2O 4 mL and added to starting 
material. Reaction was stirred at room temperature overnight. Then 6M HCl was added to 
crude mixture until pH ~3. The reaction mixture was then extracted with CH2Cl2 3 x 10 
mL. The combined organic layer was dried with Na2SO4 and evaporated. Then the product 
was recrystallized by dissolving in CH2Cl2 2 mL and allowed to recrystallize and dried 
under vacuum overnight. The 2-((4-bromophenyl)amino)benzoic acid was obtained as 
white crystal 0.078 mg (95 %yield). 1H NMR (500 MHz, Methanol-d4) δH: 7.96 (dt, J = 
8.0, 1.5 Hz, 1H), 7.41 (dq, J = 8.7, 2.2, 1.6 Hz, 2H), 7.33 (ddt, J = 8.4, 7.0, 1.4 Hz, 1H), 
7.24 – 7.18 (m, 1H), 7.15 – 7.09 (m, 2H), 6.75 (ddq, J = 8.2, 6.0, 1.1 Hz, 1H). 13C NMR 
(126 MHz, Methanol-d4) δC 170.23, 146.93, 140.28, 133.67, 131.91, 122.66, 117.38, 
114.66, 113.67, 112.74. 
6.90 g PPA was added to a 25 mL round-bottom flask with a stir bar.  The flask 
was heated to 125 °C in an oil bath.  Then 2-((4-bromophenyl)amino) benzoic acid (0.0825 
g, 0.28 mmol) was added to the flask and it was stirred for overnight.  Water (20 mL) was 
slowly added and the reaction allowed to cool to 60 °C.  After stirring for 30 min, the 
reaction was cooled to ambient temperature.  Insoluble impurities were removed by 
vacuum filtration and the pH of the solution was adjusted to 7.0 by addition of 8 M NaOH. 
Then the precipitate was purified by flash column chromatography 80:20 CH2Cl2/EtOAc 
The fractions containing product (Rf of product = 0.63) were combined, evaporated and 
dried overnight. 40 mg of 2-bromoacridin-9(10H)-one (11) were obtained as greenish 
yellow solid (52 % yield) 
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Synthesis of 2-(azetidin-1-yl)acridin-9(10H)-one 
 
 
 
 
 
 
To a solution of degassed toluene in a sealed tube, 2-bromoacridin-9(10H)-one (11, 
15 mg, 0.055 mmol) was added. Then, azetidine hydrochloride (15.4 mgm 0.165 mmol), 
Brettphos-Pd G1 (6.4 mg, 0.008 mmol), and Cs2CO3 (107 mg, 0.33 mmol) were added. 
The reaction tube was capped and stirred at 100 oC for 16 h. After the solution was allowed 
to cool to ambient temperature, the contents were filtered through a short plug of silica gel 
using CH2Cl2 to transfer the material to the silica (20 mL), and then ethyl acetate (100 mL) 
was used to elute the product.  The clarified solution was concentrated under reduced 
pressure and further purified by flash column chromatography (7:3 CH2Cl2/EtOAc) to 
afford 0.5 mg of 2-(azetidin-1-yl)acridin-9(10H)-one (6). 1H NMR (500 MHz, Methanol-
d4) δH: 8.32 (dd, J = 8.2, 1.5 Hz, 1H), 7.66 (ddd, J = 8.4, 6.8, 1.5 Hz, 1H), 7.48 (ddd, J = 
10.2, 7.9, 2.6 Hz, 2H), 7.30 (d, J = 2.7 Hz, 1H), 7.22 (ddd, J = 8.1, 6.8, 1.1 Hz, 1H), 7.11 
(dd, J = 8.9, 2.7 Hz, 1H), 3.94 (t, J = 7.2 Hz, 4H), 2.43 – 2.35 (m, 2H). 
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HTE Screening 
 Cross-coupling reactions between methyl (S)-2-((tert-butoxycarbonyl)amino)-3-
(4-(((trifluoromethyl)sulfonyl)oxy) phenyl)propanoate (2, 1.0 eq) and tert-butyl (4-amino-
3-cyanophenyl)carbamate (3, 1.5 eq) were screened by using 24-well plate. Experiments 
were set up inside a glovebox under a nitrogen atmosphere. Starting materials were dosed 
as a solution (0.1 M) in two different solvents (dioxane in row A and B, toluene in row C 
and D) into glass vials with stir bar. Then 10 mol% of Pd precatalysts including XPhos Pd 
G1, tBuXPhos Pd G1, RuPhos Pd G1, SPhos Pd G1, BrettPhos Pd G1, and XantPhos Pd 
G1 were added into column 1-6, respectively. 3.0 equivalents of base either Cs2CO3 (row 
A and C) or NaOtBu (row B and D) were then dosed. The 24-well plate was then sealed 
with screws and stirred for 16 h at 100 oC. To work up the reactions, the plate was opened 
to air and 500 µL of a solution of product standard (used as internal standard to measure 
UPLC yields) in acetonitrile (0.002 mol/L) was added into each vial. The plate was covered 
again, and the vials stirred for 10 min to ensure good homogenization. Into a separate 24-
well LC block was added 700 µL of acetonitrile, followed by 25 µL of the diluted reaction 
mixtures. The LC block was then sealed with a silicon-rubber storage mat and mounted on 
an automated UPLC instrument for analysis. 
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Synthesis of (S)-2-amino-3-(7-amino-9-oxo-9,10-dihydroacridin-2-yl)propanoic acid  
 
Methyl (S)-2-((tert-butoxycarbonyl)amino)-3-(4-(((trifluoromethyl)sulfonyl)oxy) 
phenyl)propanoate (2) (0.427 g, 1.0 mmol) was dissolved in degassed dioxane 5 mL in 
sealed tube. Then tert-butyl (4-amino-3-cyanophenyl)carbamate 0.350 g (1.50 mmol), 
BrettPhos-Pd G1 80 mg (0.1 mmol) and cesium carbonate 0.3259 g (3.0 mmol) were added 
to the tube. The reaction mixture was capped and heated to 100 °C for 16 h.  After the 
solution was allowed to cool to ambient temperature, the contents were filtered through a 
short plug of silica gel using CH2Cl2 to transfer the material to the silica and then ethyl 
acetate (50 mL) was used to elute the product.  The clarified solution was then concentrated 
under reduced pressure and further purified by flash column chromatography (50:50 
Hexane/EtOAc) to afford 0.1642 g (33 %) of methyl (S)-2-((tert-butoxycarbonyl)amino)-
3-(4-((4-((tert-butoxycarbonyl)amino)-2-cyanophenyl)amino) phenyl)propanoate (4). 1H 
NMR (500 MHz, Chloroform-d) δH: 7.61 (s, 1H), 7.28 (d, J = 9.1 Hz, 1H), 7.12 (d, J = 9.1 
Hz, 1H), 7.07 – 6.99 (m, 4H), 6.55 (s, 1H), 6.14 (s, 1H), 5.00 (d, J = 8.3 Hz, 1H), 4.68 – 
4.42 (m, 1H), 3.70 (s, 3H), 3.09 – 2.92 (m, 2H), 1.48 (s, 9H), 1.39 (s, 9H). 13C NMR (126 
MHz, Chloroform-d) δC: 172.25, 155.01, 152.81, 151.73, 142.68, 139.58, 130.86, 120.39, 
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116.54 (d, J = 124.7 Hz), 99.62, 80.39 (d, J = 126.3 Hz), 60.31, 54.41, 52.16, 37.71, 28.23, 
14.10. 
A solution of 13.5 M sulfuric acid (5 mL) was added to a flask containing methyl 
(S)-2-((tert-butoxycarbonyl)amino)-3-(4-((4-((tert-butoxycarbonyl)amino)-2-cyano 
phenyl)amino)phenyl)propanoate 0.1642 g (0.32 mmol). The flask was then fitted with a 
reflux condenser and heated to 115 °C for 2 days in an oil bath.  40 mL of water was then 
added to the flask and allowed to stir for 15 min.  The reaction was removed from the hot 
oil bath and allowed to cool down to room temperature. 50 g of ion-exchange resin 
(DowexÒ 50WX8 hydrogen form, strongly acidic cation exchange resin) was made into a 
slurry with 1.8 M aqueous H2SO4 and applied to a flash chromatography column.  The resin 
was washed with 350 mL 1.8 M aqueous H2SO4, 2 L of water, 1 L of 1.5 M aqueous 
NH4OH, and 4 L of water.  Following these washes, the resin was dried by passing air 
through the column.  The cooled Aad solution was then vacuum filtered on a Büchner 
funnel to remove precipitated material, and the clarified solution was applied to the washed 
and dried ion-exchange resin.  The resulting resin slurry was shaken in the chromatography 
column for 5 min before the solution was drained.  This solution was then reapplied to the 
dried resin and shaken for an additional 5 min.  The twice-passed solution was then set 
aside.  The loaded resin was washed with 4 L water before the compound of interest was 
eluted with 1.45 L of 1.5 M NH4OH.  The solution was concentrated to 50 mL by rotary 
evaporation, and then lyophilized to dryness, yielding 40 mg of Aad as a yellow powder 
42% yield. ESI-LRMS and NMR spectra matched previous reports.108 
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Spectroscopic Characterization of Substituted Aminoacridones 
Prior to spectroscopic characterization, stocks of all acridone compounds were 
prepared in acetonitrile at a concentration of 200 or 300 µM.  All absorbance and 
fluorescence measurements were taken in 1:1 CH3CN/PBS buffer (PBS, 137 mM NaCl, 
2.7 mM KCl, 10 mM Na2HPO4, 2 mM KH2PO4, pH 7.4).  Absorbance measurements were 
acquired at concentrations of 75 and 7.5 µM for proper visualization of the spectral profile 
above and below ~300 nm. 
Fluorescence measurements were acquired under identical solution conditions at 
concentrations of 7.5 µM for all compounds.  Spectra were collected using excitation 
wavelengths matching the maximum absorbance wavelength for each analog measured.  
The collection window started 15 nm from the excitation wavelength and extended to 650 
nm.  This window was truncated to no less than a total range of 150 nm for more blue 
shifted chromophores.  All slit widths were set to 1.5 nm and spectra were acquired with 
an integration time of 0.25 sec/nm. 
Extinction coefficients were calculated from absorbance measurements collected 
on a Tecan M1000 plate reader (Mannedorf, Switzerland).  Samples containing 100, 80, 
60, 40 and 20 µM chromophore were prepared in 1:1 CH3CN/PBS solution with a total 
sample volume of 100 µL.  Following brief vortexing, samples were loaded into a Corning 
CoStar black, clear bottom, 96-well plate.  Emission spectra are shown normalized to the 
acridone emission at 412 nm to approximate quantum yields. 
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Amino Acid Activation by Acd Aminoacyl tRNA Synthetase (AcdRS) 
(These experiments were performed in collaboration with Zach Hosteteler.) 
AcdRS Expression and Purification. We had previously generated recombinant Acd 
aminoacyl tRNA synthetase (AcdRS2b) by overexpressing polyHis-tagged AcdRS2b from 
a pBAD construct in arabinose auto-induction media and purifying the enzyme using both 
cobalt and heparin affinity columns.88  For our amino acid activation assay, we used an 
enzyme aliquot from that AcdRS2b preparation, which we had exchanged into buffer (50 
mM HEPES-KOH pH 7.5, 20 mM NaCl, 10 mM MgCl2, 1 mM DTT, 50% glycerol) and 
stored at -80 °C. 
 
AcdRS Activity Test Using a Malachite Green Assay. As previously described,88 we 
tested the activity of AcdRS2b with either Acd or Aad using an adapted form of an enzyme-
coupled, colorimetric assay.79  Formation of inorganic pyrophosphate (PPi) during the 
amino acid activation step of the reaction is coupled to the activity of inorganic 
pyrophosphatase (PPiase), which splits PPi into two inorganic phosphate (Pi) molecules.  
Under acidic conditions, free Pi reacts with Malachite green to produce a colored Malachite 
green phosphomolybdate complex (absorbing at 600-660 nm).  Since our AcdRS2b freezer 
stock only retained partial activity (data not shown), we chose conditions that drove the 
amino acid activation reaction toward completion.  We prepared reactions in triplicate 
containing reaction buffer (50 mM HEPES-KOH pH 7.5, 20 mM NaCl, 10 mM MgCl2, 1 
mM DTT), 0.2 mM ATP, 2 U/mL PPiase (NEB), 250 µM amino acid substrate (Acd or 
Aad), and 4 µM AcdRS2b enzyme.  To control for background phosphate signal in our 
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reactions, we excluded AcdRS2b enzyme; to demonstrate the ATP-dependence of the 
amino acid activation reaction, we also prepared reactions excluding ATP.  Reactions were 
incubated at 37 °C for 100 min, then quenched with three reaction volumes of ice-cold 
EDTA solution to a final concentration of 10 mM.  Quenched reactions were developed 
with Malachite green per kit instructions (Malachite Green Phosphate Assay Kit, Sigma 
#MAK307) in a 96-well plate (Corning Costar).  Absorbance at 620 nm was measured in 
an Infinite F200 plate reader (Tecan), and a Pi standard curve was used to calculate 
phosphate concentration in each reaction.  Data were reported as mean and standard 
deviation (n=3) of amount of PPi formed after subtracting the background signal from the 
no enzyme control reactions. 
 
Aad Docking Model. The structure of 2-aminoacridone was optimized in Gaussian at the 
AM1 level of theory with a 6-31G basis set.  The optimized structure was aligned with the 
sidechain of Acd docked into a homology model of AcdRS2b built using the crystal 
structure coordinates, as previously described.64, 88  The 2-aminoacridone molecule was 
aligned to position the amino group as in Aad.  Steric clashes with the sidechains of Val164 
and Ala167 were observed. 
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